News | Novartis

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ og: http://ogp.me/ns# rdfs: http://www.w3.org/2000/01/rdf-schema# schema: http://schema.org/ sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema# "> <head> <meta charset="utf-8" /> <meta name="description" content="News and more from the frontiers of medicine." /> <meta name="abstract" content="News and more from the frontiers of medicine." /> <link rel="canonical" href="https://www.novartis.com/news" /> <meta property="og:site_name" content="Novartis" /> <meta property="og:type" content="Website" /> <meta property="og:url" content="https://www.novartis.com/news" /> <meta property="og:title" content="News | Novartis" /> <meta property="og:description" content="News and more from the frontiers of medicine." /> <meta property="og:image" content="https://www.novartis.com/sites/novartis_com/files/2021-01/novartis-logo-open-graph.jpg" /> <meta property="og:image:url" content="https://www.novartis.com/sites/novartis_com/files/2021-01/novartis-logo-open-graph.jpg" /> <meta property="og:image:secure_url" content="https://www.novartis.com/sites/novartis_com/files/2021-01/novartis-logo-open-graph.jpg" /> <meta property="og:image:alt" content="Novartis logo" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:description" content="News and more from the frontiers of medicine." /> <meta name="twitter:site" content="@novartis" /> <meta name="twitter:title" content="News" /> <meta name="twitter:site:id" content="17226612" /> <meta name="twitter:creator" content="@novartis" /> <meta name="twitter:creator:id" content="17226612" /> <meta name="twitter:url" content="https://www.novartis.com/news" /> <meta name="twitter:image" content="https://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg" /> <meta name="twitter:image:alt" content="Novartis logo" /> <meta name="google-site-verification" content="Ml04WfS7Ss3mQoi-HOUTHQazFh1Fl28fYjOLLtaJSLc" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" /> <script type="application/ld+json">{ "@context": "https://schema.org", "@graph": [ { "@type": "WebPage", "@id": "https://www.novartis.com/", "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.novartis.com/" }, { "@type": "ListItem", "position": 2, "name": "News", "item": "https://www.novartis.com/news" } ] }, "description": "News and more from the frontiers of medicine.", "publisher": { "@type": "Organization", "@id": "https://www.novartis.com/", "name": "Novartis", "url": "https://www.novartis.com/", "sameAs": [ "https://www.twitter.com/novartis", "https://www.linkedin.com/company/novartis", "https://www.youtube.com/user/novartis", "https://www.facebook.com/novartis", "https://www.instagram.com/novartis" ], "logo": { "@type": "ImageObject", "url": "https://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg" } } } ] }</script> <meta http-equiv="x-ua-compatible" content="ie=edge" /> <link rel="icon" href="/themes/custom/polaris/favicon.ico" type="image/vnd.microsoft.icon" /> <link rel="alternate" hreflang="en" href="https://www.novartis.com/news" /> <link rel="preconnect" href="https://cdn.cookielaw.org" /> <script>window.a2a_config=window.a2a_config||{};a2a_config.callbacks=[];a2a_config.overlays=[];a2a_config.templates={};</script> <title>News | Novartis</title> <link rel="stylesheet" media="all" href="/sites/novartis_com/files/css/css_ITuaUzAm_FoY8p2vyYvgee_NHG__IkpUueKPM2Mu07A.css?delta=0&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <link rel="stylesheet" media="all" href="//cdnjs.cloudflare.com/ajax/libs/font-awesome/6.6.0/css/all.min.css" /> <link rel="stylesheet" media="all" href="/sites/novartis_com/files/css/css_Hfsnn5F_vPzrlrE4w7L6sJztyrTXsnnsNfKdKcf5F-s.css?delta=2&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <link rel="stylesheet" media="all" href="/sites/novartis_com/files/css/css_tWrUDgnDm4bAtzkTCRrTrFfZtq3-LjZY-Q4OPIP-e4k.css?delta=3&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <link rel="stylesheet" media="print" href="/sites/novartis_com/files/css/css_eiZxMRVlU_CSnYDTbK00lu0VngxlF0Y34INSYoOC_5s.css?delta=4&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <link rel="stylesheet" media="all" href="/sites/novartis_com/files/css/css_dkS3lXCr_jP3tr8NkaDkKBConRcV28LiPkydiPL8bFc.css?delta=5&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <link rel="stylesheet" media="print" href="/sites/novartis_com/files/css/css_JFnvM_xGtXbn9VYiPkxUID0yO6nppKPkGZeLrVGQ1sw.css?delta=6&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <link rel="stylesheet" media="all" href="/sites/novartis_com/files/css/css_Rk2lH5-SxzL1vz5gNqTU9RRYjbO8x-zm2KyiHoAOLt0.css?delta=7&language=en&theme=polaris&include=eJx1UtGO3CAM_CESpF6lfo7lgJOlCxhhs7n9-3Ny2_Sh2xfAA_bM2GCMylifHl-Hee1c1aEIKaT6m4Jy90Fkxh7g58evHx-wdL5ThWY5qW7AK-iNYE0Va0iYoZOMrAKKS6Z3pVLBjSB0bo0icIVKu4AR3NLjbcJ5n5Powaf0qaB91IBK0VmUU7372EfDPL9CJ3xqKRQTwoGI_xeaTXghJ09RKn5BIbcwq2jHBgv2nthvmRfMk-jTUjbXOGNP4q93F1LMdJqEsumeopmLvFf3SJEYqCzm9I5ZR0f_2r_Rd0pXmwHuJFxoDlwaV7KhNOy4GeNN_pj9i8yjtrFYi25W8ZGsX_5c58Jx5De2Vu7lkh6tkx3rRi2FO3W3k8nZsFAd58N5p-kApgOZzi9CNboaIFvWOKb57dvmdSGBR9X-vG7cQmo0QJ-Nxbqxpmyh-I2qkWcndPwAwJYAh_LhO5OS_w9-ic_avwCrRxmt&0=srtw6f" /> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/24551","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_environment":false},"tagIds":["GTM-57RJQ5"]},"gtag":{"tagId":"","consentMode":false,"otherIds":[],"events":[],"additionalConfigInfo":[]},"ajaxPageState":{"libraries":"eJx1VO2S2yAMfCFjZq6ddvo0GtlWbC6AGCSSy9tXOImvvY8_NloJWK9WxmVRxnzz-FiMp8pZB6yzhtknWgK62RB6ByUouROzUn1AMHMl_896TJhxpQVOIRK0EhkXS6QSSQnoYqf10KqW5xGiPJ_BVmeq_t9gQBFSCPmVZuXqZ5HR9sDPH79ffsBU-UwZivEPeQU-gW5k12bMc8AIlaRFFVCcIn11VEhGFObKpRhfzpDpKmAXbOHy5YY9H4Nov0_pTUFryzMqLR_LXx9MX37_-gOycbVaqgkob0aPUpfhwXijynDBGtCwINKoc0k8TKS2B-itsNwFtVA8NmWQNqWg35WslKliHCZrlWjFAhPWGtifuKbP6Bp5wuhEb9G-7HPe0LMMM_M5UKnsj9WwoGLEm_Vtog0vgasMpkvf4JfaCsbxEQ4r82qOUFz9ao-P8Yiv-PY_mIY8Q8S8tt4noXiX9kBmblnr7cgMBSuuxnuT5-XvyNhyaZM1b7NmFY6mt0mpnJx11hXsOmYXcTqShwwHYl9rsuaVyt2eT_yDfk846ntJMisGd2fqFrPcwtd8ZPNF3O5Gt2KMVG9H5hIWYldMY9eNNwh1fwKWAN0Hz8Hy3-CD8D4L-zTD3kfzQFa8knCisddx7hP-ReFnaDS_Jjv0JkrJTyg07ASB0mT2O2PUVtE_3nfUKmxs_P4cEy_NhvFKduqKNgVtt-R4JdcB1xG3_4coL38BkjnTlQ","theme":"polaris","theme_token":null},"ajaxTrustedUrl":{"\/search":true,"\/news\/news-archive":true},"cookiepro":{"uuid":"fe8dfb2c-2701-45db-8577-13675c68ed60"},"dataLayer":{"defaultLang":"en","languages":{"en":{"id":"en","name":"English","direction":"ltr","weight":0},"de":{"id":"de","name":"German","direction":"ltr","weight":1},"fr":{"id":"fr","name":"French","direction":"ltr","weight":2}}},"data":{"extlink":{"extTarget":true,"extPopup":{"id":"external_link","title":"You are now leaving the Novartis.com website","body":"\u003Cp\u003EThis link will take you to a website to which our \u003Ca aria-label=\u0022Privacy Policy\u0022 data-entity-substitution=\u0022canonical\u0022 data-entity-type=\u0022node\u0022 data-entity-uuid=\u0022201c42b8-6750-43c5-89b8-37de05f57981\u0022 href=\u0022\/privacy\/privacy-policy\u0022 rel=\u0022 noopener\u0022 target=\u0022_blank\u0022 title=\u0022Privacy Policy\u0022\u003EPrivacy Policy\u003C\/a\u003E does not apply. You are solely responsible for your interactions with that website.\u003C\/p\u003E","labelyes":"Continue","labelno":"Cancel","target":"_blank"},"extPopupFlag":true,"extTargetNoOverride":true,"extNofollow":true,"extNoreferrer":true,"extFollowNoOverride":false,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":false,"extExclude":"","extInclude":"^(?:https?:\\\/\\\/)?(?:((?!www\\.)[^.]+\\.)|([^.]+\\.)|)novartis\\.com(?:\\.[a-z]{2}|\\\/[a-z]{2}-[a-z]{2})?$","extCssExclude":".off-url,\r\n.arctic_over_view_toggle.arctic_grid_view .item-list ul.whole-item .each-item,\r\n.node--type-story-page a.button-border ","extCssExplicit":"","extAlert":true,"mailtoClass":"0","mailtoLabel":"(link sends email)","extUseFontAwesome":false,"extIconPlacement":"append","extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","whitelistedDomains":["ml-eu.globenewswire.com","novartis.webcasts.com"]}},"news_archive":{"date_range":"Date Range","all_label":"All","last_seven_days":"Last 7 Days","last_thirty_days":"Last 30 Days","last_six_months":"Last 6 months","custom_label":"Custom","clear_all_label":"Clear all","start_date_label":"Start Date","end_date_label":"End Date","month_short":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"month_names":{"1":"January","2":"February","3":"March","4":"April","5":"May","6":"June","7":"July","8":"August","9":"September","10":"October","11":"November","12":"December"},"week_days":["Su","Mo","Tu","We","Th","Fr","Sa"]},"search_api_autocomplete":{"global_search":{"min_length":3}},"arctic_core":{"accessibility_text":null,"palettes_list":["#0460A9","#EC9A1E","#E74A21","#8D1F1B","#221F1F","#656565","#C7C7C7","#E4E4E4"]},"ajax":[],"user":{"uid":0,"permissionsHash":"82b15e8483c40733690212bef7d674e3094302828dd5a389a9586c217ce26ba2"}}</script> <script src="/sites/novartis_com/files/js/js_zqe2sfUiCtwcjLhShTRZphxjnfmeImoGOFhhNFtZd3E.js?scope=header&delta=0&language=en&theme=polaris&include=eJx1kuuO3CAMhV-IBGlVterTWA7xECaAkXGyk7ev57LRdqX5hc9nrGOMcZ6VsR4eX8F4Ea7qUIKmAF05rGDRSuK_C4e9k0KqVwrK4q99tBL49fHn91_oC4uCkhSgumANVKgq8AV0IVhIGHaUhMZS7xsBVyjsZlTMeJjTRAvuiaU7umlOdfWzbA3z-JJuYtaugg0mFEnsY-YJ89D1sHx0jbMZ9Hf4LD_JnmbioZn9kFPXk9e9D6lgpCFiziSHe9wEKhPNsGLWTdC_zid1kTlmAsXoo5b_JcafesQr3lxgXhM1YX9GZw82FxKskdpz9J8EhSLaTDd_YSnjJw13MNzJ8Pg_qrOrAbJVbdY8dMrPfzpJ4K2qHGfGTaRmA3Rr3O1pl5RN2gSpmnl-l8ZNGfo2laSuk63AAtgS3HHg0jIp-Tf8a8cCC_lv8ViwWocPD4KtZcYZvoqA9vsqmbRb8z8xhhVI&0=srtw6f" data-ot-ignore></script> <script src="/modules/contrib/google_tag/js/gtm.js?srtw6f" data-ot-ignore></script> <script src="/modules/contrib/google_tag/js/gtag.js?srtw6f" data-ot-ignore></script> <script src="/modules/contrib/cookiepro/js/cookiepro.js?srtw6f" data-ot-ignore></script> </head> <body class="layout-no-sidebars page-node-24551 path-node node--type-landing-page pattern-no_color-no_pattern alert_popup_show_once content-news"> <a href="#main" class="visually-hidden focusable skip-link"> Skip to main content </a> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-57RJQ5" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="arc-fixed"> <div class="alert-banner-region"> </div> <header id="header" class="header" aria-label="Site header"> <div class="full-width-navbar"> <nav class="navbar navbar-expand-xl" id="navbar-main"> <a href="/" rel="home" class="navbar-brand"> <img src="/themes/custom/polaris/logo.svg" alt="Novartis" title="Home" class="img-fluid d-inline-block align-top novartis-logo" /> </a> <div class="novartis_whole_menu"> <div class="top-search-block"> <ul id="block-nvs-arctic-account-menu-top-search-block" class="clearfix nav simple-menu"> <li class="nav-item search"> <button class="nav-link nav-link-"> <img class="icon-search" src="/themes/custom/polaris/patterns/images/icon-search.svg" alt="Open"> <img class="icon-close" src="/themes/custom/polaris/patterns/images/icon-close.svg" alt="Close"> <span class="text-search">Search</span> </button> <div class="views-exposed-form bef-exposed-form block block-views block-views-exposed-filter-blockglobal-search-global-search" data-bef-auto-submit-full-form="" data-bef-auto-submit="" data-bef-auto-submit-delay="500" data-drupal-selector="views-exposed-form-global-search-global-search" id="block-polaris-exposedformglobal-searchglobal-search" data-block-plugin-id="views_exposed_filter_block:global_search-global_search"> <div class="content"> <form action="/search" method="get" id="views-exposed-form-global-search-global-search" accept-charset="UTF-8" class="views-exposed-form-global-search-global-search"> <div class="wrap-global-search-result container"> <div class="js-form-item js-form-type-search-api-autocomplete form-type-search-api-autocomplete js-form-item-keyword form-item-keyword form-no-label mb-3"> <label for="edit-keyword--9" class="visually-hidden">Site Search</label> <div> <input placeholder="Search" data-drupal-selector="edit-keyword" data-search-api-autocomplete-search="global_search" class="form-autocomplete form-text form-control arc-input" data-autocomplete-path="/search_api_autocomplete/global_search?display=global_search&&filter=keyword" type="text" id="edit-keyword--9" name="keyword" value="" size="30" maxlength="128"/> </div> </div> <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper mb-3" id="edit-actions--9"><div> <input data-bef-auto-submit-click="" data-drupal-selector="edit-submit-global-search" type="submit" id="edit-submit-global-search" value="Apply" class="button js-form-submit form-submit btn btn-primary form-control arc-input"/> </div> </div> <div class="count-filters"> </div> </div> <div class="search-clear-all"><div> <input onclick="clearAllFilterButton(); return false;" data-drupal-selector="edit-button" type="submit" id="edit-button" name="op" value="Clear All" class="button js-form-submit form-submit form-control arc-input"/> </div> </div> </form> </div> </div> </li> </ul> </div> <div id="block-polaris-languagecountryselectorfordesktop" data-block-plugin-id="novartis_language_selector" class="block block-nc-language-selector block-novartis-language-selector"> <div class="content">  <div class="language-selector-header-block language-selector-header-desktop" id="language-selector-header-block"> <div class="language-selector-name triangle-icon"> <img src="/themes/custom/polaris/patterns/images/globe.svg" alt="language-selector-globe"> <a class="site-selector-anchor-link-toggle" aria-label="Current site selection Global |en" href="#">Global <span>|</span> <strong>en </strong></a> </div> </div>  <div class="language-selector-desktop"> <div class="ls-title"> <div role="heading" class="h2" aria-label="Choose Location" aria-level="2"> <span>Choose Location</span> </div> </div> <div class="tab-content-block"> <div class="region-tabs">  <ul class="nav nav-pills"> <li class="nav-item"> <a class="nav-link active" href="#international" data-bs-toggle="pill"><strong>International</strong></a> </li> <li class="nav-item"> <a class="nav-link" href="#americas" data-bs-toggle="pill"><strong>Americas</strong></a> </li> <li class="nav-item"> <a class="nav-link" href="#asia-pacific" data-bs-toggle="pill"><strong>Asia Pacific</strong></a> </li> <li class="nav-item"> <a class="nav-link" href="#europe" data-bs-toggle="pill"><strong>Europe</strong></a> </li> <li class="nav-item"> <a class="nav-link" href="#middle-east-africa" data-bs-toggle="pill"><strong>Middle East & Africa</strong></a> </li> </ul> </div> </div> <div class="tab-content">  <div id=international class="tab-pane active"> <dl class="countries-list">  <dt></dt> <dd> <a href="https://www.novartis.com/" target="_self" class="active">Global | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartisfoundation.org" target="_self">Novartis Foundation | <strong>English</strong></a> </dd> </dl> </div> <div id=americas class="tab-pane"> <dl class="countries-list">  <dt></dt> <dd> <a href="https://www.novartis.com/ar-es/" target="_self">Argentina | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/br-pt/" target="_self">Brazil | <strong>Português</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ca-en/" target="_self">Canada | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ca-fr/" target="_self">Canada | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/candean-es/" target="_self">Central America | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/co-es/" target="_self">Colombia | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/mx-es/" target="_self">Mexico | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/us-en/" target="_self">United States | <strong>English</strong></a> </dd> </dl> </div> <div id=asia-pacific class="tab-pane"> <dl class="countries-list">  <dt></dt> <dd> <a href="https://www.novartis.com/au-en/" target="_self">Australia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/bd-en/" target="_self">Bangladesh | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/hk-zh/" target="_self">Hong Kong S.A.R. | <strong>繁體中文</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/in-en/" target="_self">India | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/id-en/" target="_self">Indonesia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/jp-ja/" target="_self">Japan | <strong>日本語</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/kr-ko/" target="_self">Korea | <strong>한국어</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com.cn/" target="_self">Mainland China | <strong>中文</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/my-en/" target="_self">Malaysia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/pk-en/" target="_self">Pakistan | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ph-en/" target="_self">Philippines | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/sg-en/" target="_self">Singapore | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/tw-zh/" target="_self">Taiwan | <strong>繁體中文</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/th-th/" target="_self">Thailand | <strong>ภาษาไทย</strong></a> </dd> </dl> </div> <div id=europe class="tab-pane"> <dl class="countries-list">  <dt></dt> <dd> <a href="https://www.novartis.com/at-de/" target="_self">Austria | <strong>Deutsch</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/be-fr/" target="_self">Belgium | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/be-nl/" target="_self">Belgium | <strong>Nederlands</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/bg-bg/" target="_self">Bulgaria | <strong>Български</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/cz-cs/" target="_self">Czech Republic | <strong>Česky</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/cz-en/" target="_self">Czech Republic | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/dk-da/" target="_self">Denmark | <strong>Dansk</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ee-et/" target="_self">Estonia | <strong>Eesti</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/fi-fi/" target="_self">Finland | <strong>Suomalainen</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/fr-fr/" target="_self">France | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/de-de/" target="_self">Germany | <strong>Deutsch</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/gr-el/" target="_self">Greece | <strong>Ελληνικά</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/hu-hu/" target="_self">Hungary | <strong>Magyar</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ie-en/" target="_self">Ireland | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/it-it/" target="_self">Italy | <strong>Italiano</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/lv-lv/" target="_self">Latvia | <strong>Latvian</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/lt-lt/" target="_self">Lithuania | <strong>Lithuanian</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/nl-nl/" target="_self">Netherlands | <strong>Nederlands</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/no-no/" target="_self">Norway | <strong>Norsk</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/pl-pl/" target="_self">Poland | <strong>Polski</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/pt-pt/" target="_self">Portugal | <strong>Português</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ro-ro/" target="_self">Romania | <strong>Română</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ru-ru/" target="_self">Russia | <strong>Русский</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/rs-sr/" target="_self">Serbia | <strong>Srpski</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/sk-sk/" target="_self">Slovakia | <strong>Slovensky</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/si-sl/" target="_self">Slovenia | <strong>Slovenščina</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/si-en/" target="_self">Slovenia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/es-es/" target="_self">Spain | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/se-se/" target="_self">Sweden | <strong>Svenska</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ch-de/" target="_self">Switzerland | <strong>Deutsch</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ch-fr/" target="_self">Switzerland | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/tr-tr/" target="_self">Türkiye | <strong>Türkçe</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/uk-en/" target="_self">United Kingdom | <strong>English</strong></a> </dd> </dl> </div> <div id=middle-east-africa class="tab-pane"> <dl class="countries-list">  <dt></dt> <dd> <a href="https://www.novartis.com/eg-en/" target="_self">Egypt | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/il-he/" target="_self">Israel | <strong>עברית</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/sa-ar/" target="_self">Saudi Arabia | <strong>العربية</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/za-en/" target="_self">South Africa | <strong>English</strong></a> </dd> </dl> </div> </div> </div> </div> </div> <div id="block-polaris-languagecountryselectorformobile" data-block-plugin-id="nc_language_selector_mobile" class="block block-nc-language-selector block-nc-language-selector-mobile"> <div class="content"> <div id="block-languagecountryselectorformobile" data-block-plugin-id="novartis_language_selector_mobile" class="block block-novartis-language-selector block-novartis-language-selector-mobile block-wrapper"> <div class="language-selector-header-block-mobile language-selector-header-mobile" id="language-selector-header-block-mobile"> <div class="language-selector-name triangle-icon"> <img src="/themes/custom/polaris/patterns/images/globe.svg" alt="language-selector-globe"> <a class="site-selector-anchor-link-toggle" href="#" aria-label="Current site selection Global"> <span>Global </span> </a> </div> </div> <div class="language-selector-mobile"> <div class="brand-quinary-light"> <div class="heading"> <div class="h3" aria-label="Choose Location" role="heading" aria-level="3"> <span>Choose Location</span> </div> </div> <div class="tab-content-block-mobile"> <div class="region-selector-wrapper"> <div class="dropdown dropdown-select"> <button class="dropdown-toggle" type="button" id="dropdownMenuButton" data-selected-region="international" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> <strong><strong>international</strong></strong> </button> <div class="dropdown-menu" > <a class="dropdown-item" data-region="international" href="#international">International</a> <a class="dropdown-item" data-region="americas" href="#americas">Americas</a> <a class="dropdown-item" data-region="asia-pacific" href="#asia-pacific">Asia Pacific</a> <a class="dropdown-item" data-region="europe" href="#europe">Europe</a> <a class="dropdown-item" data-region="middle-east-africa" href="#middle-east-africa">Middle East & Africa</a> </div> </div> </div> </div> <div class="countrylist-wrapper"> <dl class="countries-list">  <dt></dt> <dd> <a href="https://www.novartis.com/ar-es/" target="_self" data-region-identifier="americas">Argentina | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/au-en/" target="_self" data-region-identifier="asia-pacific">Australia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/at-de/" target="_self" data-region-identifier="europe">Austria | <strong>Deutsch</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/bd-en/" target="_self" data-region-identifier="asia-pacific">Bangladesh | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/be-fr/" target="_self" data-region-identifier="europe">Belgium | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/be-nl/" target="_self" data-region-identifier="europe">Belgium | <strong>Nederlands</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/br-pt/" target="_self" data-region-identifier="americas">Brazil | <strong>Português</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/bg-bg/" target="_self" data-region-identifier="europe">Bulgaria | <strong>Български</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ca-en/" target="_self" data-region-identifier="americas">Canada | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ca-fr/" target="_self" data-region-identifier="americas">Canada | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/candean-es/" target="_self" data-region-identifier="americas">Central America | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/co-es/" target="_self" data-region-identifier="americas">Colombia | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/cz-cs/" target="_self" data-region-identifier="europe">Czech Republic | <strong>Česky</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/cz-en/" target="_self" data-region-identifier="europe">Czech Republic | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/dk-da/" target="_self" data-region-identifier="europe">Denmark | <strong>Dansk</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/eg-en/" target="_self" data-region-identifier="middle-east-africa">Egypt | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ee-et/" target="_self" data-region-identifier="europe">Estonia | <strong>Eesti</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/fi-fi/" target="_self" data-region-identifier="europe">Finland | <strong>Suomalainen</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/fr-fr/" target="_self" data-region-identifier="europe">France | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/de-de/" target="_self" data-region-identifier="europe">Germany | <strong>Deutsch</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/gr-el/" target="_self" data-region-identifier="europe">Greece | <strong>Ελληνικά</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/hk-zh/" target="_self" data-region-identifier="asia-pacific">Hong Kong S.A.R. | <strong>繁體中文</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/hu-hu/" target="_self" data-region-identifier="europe">Hungary | <strong>Magyar</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/in-en/" target="_self" data-region-identifier="asia-pacific">India | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/id-en/" target="_self" data-region-identifier="asia-pacific">Indonesia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ie-en/" target="_self" data-region-identifier="europe">Ireland | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/il-he/" target="_self" data-region-identifier="middle-east-africa">Israel | <strong>עברית</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/it-it/" target="_self" data-region-identifier="europe">Italy | <strong>Italiano</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/jp-ja/" target="_self" data-region-identifier="asia-pacific">Japan | <strong>日本語</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/kr-ko/" target="_self" data-region-identifier="asia-pacific">Korea | <strong>한국어</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/lv-lv/" target="_self" data-region-identifier="europe">Latvia | <strong>Latvian</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/lt-lt/" target="_self" data-region-identifier="europe">Lithuania | <strong>Lithuanian</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com.cn/" target="_self" data-region-identifier="asia-pacific">Mainland China | <strong>中文</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/my-en/" target="_self" data-region-identifier="asia-pacific">Malaysia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/mx-es/" target="_self" data-region-identifier="americas">Mexico | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/nl-nl/" target="_self" data-region-identifier="europe">Netherlands | <strong>Nederlands</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/no-no/" target="_self" data-region-identifier="europe">Norway | <strong>Norsk</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/" target="_self" data-region-identifier="international" class="active">Global | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartisfoundation.org" target="_self" data-region-identifier="international">Novartis Foundation | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/pk-en/" target="_self" data-region-identifier="asia-pacific">Pakistan | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ph-en/" target="_self" data-region-identifier="asia-pacific">Philippines | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/pl-pl/" target="_self" data-region-identifier="europe">Poland | <strong>Polski</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/pt-pt/" target="_self" data-region-identifier="europe">Portugal | <strong>Português</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ro-ro/" target="_self" data-region-identifier="europe">Romania | <strong>Română</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ru-ru/" target="_self" data-region-identifier="europe">Russia | <strong>Русский</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/sa-ar/" target="_self" data-region-identifier="middle-east-africa">Saudi Arabia | <strong>العربية</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/rs-sr/" target="_self" data-region-identifier="europe">Serbia | <strong>Srpski</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/sg-en/" target="_self" data-region-identifier="asia-pacific">Singapore | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/sk-sk/" target="_self" data-region-identifier="europe">Slovakia | <strong>Slovensky</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/si-sl/" target="_self" data-region-identifier="europe">Slovenia | <strong>Slovenščina</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/si-en/" target="_self" data-region-identifier="europe">Slovenia | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/za-en/" target="_self" data-region-identifier="middle-east-africa">South Africa | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/es-es/" target="_self" data-region-identifier="europe">Spain | <strong>Español</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/se-se/" target="_self" data-region-identifier="europe">Sweden | <strong>Svenska</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ch-de/" target="_self" data-region-identifier="europe">Switzerland | <strong>Deutsch</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/ch-fr/" target="_self" data-region-identifier="europe">Switzerland | <strong>Français</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/tw-zh/" target="_self" data-region-identifier="asia-pacific">Taiwan | <strong>繁體中文</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/th-th/" target="_self" data-region-identifier="asia-pacific">Thailand | <strong>ภาษาไทย</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/tr-tr/" target="_self" data-region-identifier="europe">Türkiye | <strong>Türkçe</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/uk-en/" target="_self" data-region-identifier="europe">United Kingdom | <strong>English</strong></a> </dd> <dt></dt> <dd> <a href="https://www.novartis.com/us-en/" target="_self" data-region-identifier="americas">United States | <strong>English</strong></a> </dd> </dl> </div> </div> </div> </div> </div> </div> <div class="top-menu-block" > <ul id="block-nvs-arctic-account-menu-top-menu-block" class="clearfix nav simple-menu"> <li class="nav-item menu"> <button class="nav-link nav-link- " aria-label="Menu">Menu</button> <div id="block-polaris-mainnavigation" data-block-plugin-id="we_megamenu_block:main" class="block block-we-megamenu block-we-megamenu-blockmain"> <div class="content"> <div class="region-we-mega-menu"> <nav class="main navbar navbar-default navbar-we-mega-menu mobile-collapse hover-action" data-menu-name="main" data-block-theme="polaris" data-style="Default" data-animation="None" data-delay="" data-duration="" data-autoarrow="" data-alwayshowsubmenu="" data-action="hover" data-mobile-collapse="0"> <div class="container-fluid"> <ul class="we-mega-menu-ul nav nav-tabs"> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="a46d0c6e-3317-47f0-a74d-91328196819d" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="About" href="/about" > <i class="borderH"></i> About  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="1b48ced5-2013-42f5-b94e-6c59d5961cda" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Board of Directors" href="/about/board-directors" > <i class="borderH"></i> Board of Directors  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="ceb853f6-72b8-4e3f-8776-a02096b7d183" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Joerg Reinhardt" href="/about/board-directors/joerg-reinhardt" > <i class="borderH"></i> Joerg Reinhardt  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="91cd64e6-8b87-4882-85eb-9b209887bc92" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Simon Moroney" href="/about/board-directors/simon-moroney" > <i class="borderH"></i> Simon Moroney  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="1795ff34-2e6b-4c9d-97d5-e3f956a628e8" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Nancy C. Andrews" href="/about/board-directors/nancy-c-andrews" > <i class="borderH"></i> Nancy C. Andrews  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="5a244327-ea6b-46dd-a155-c52b93507adf" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Ton Buechner" href="/about/board-directors/ton-buechner" > <i class="borderH"></i> Ton Buechner  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="fdc8c6da-66b7-42e5-85cc-a6279613bdb9" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patrice Bula" href="/about/board-directors/patrice-bula" > <i class="borderH"></i> Patrice Bula  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="493c74c0-80e4-46c0-9789-0e11f0f30588" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Elizabeth (Liz) Doherty" href="/about/board-directors/elizabeth-liz-doherty" > <i class="borderH"></i> Elizabeth (Liz) Doherty  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="dc3b9eae-7ba3-4c9c-98d7-a3b19b9b6071" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Ana de Pro Gonzalo" href="/about/board-directors/ana-de-pro-gonzalo" > <i class="borderH"></i> Ana de Pro Gonzalo  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="0bde6d1a-3172-4eef-a1c7-986c8947224d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Bridgette Heller" href="/about/board-directors/bridgette-heller" > <i class="borderH"></i> Bridgette Heller  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="f77f5fe9-07cb-427d-ac05-537894139dd9" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Daniel Hochstrasser" href="/about/board-directors/daniel-hochstrasser" > <i class="borderH"></i> Daniel Hochstrasser  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="cb9adc29-95c8-482a-933b-482df8e40875" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Frans van Houten" href="/about/board-directors/frans-van-houten" > <i class="borderH"></i> Frans van Houten  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="ee6993d0-1940-4b9d-bc03-1de219cc3acc" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Charles L. Sawyers" href="/about/board-directors/charles-l-sawyers" > <i class="borderH"></i> Charles L. Sawyers  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="df33adf0-bcf2-4afd-a6d3-769479b30d90" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="William T. Winters" href="/about/board-directors/william-t-winters" > <i class="borderH"></i> William T. Winters  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="6ac88867-45e6-4552-b85c-aff2ddcdc376" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="John D. Young" href="/about/board-directors/john-d-young" > <i class="borderH"></i> John D. Young  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="415bca80-fd7f-436f-a86f-6274fe7a5428" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Charlotte Pamer-Wieser" href="/about/board-directors/charlotte-pamer-wieser" > <i class="borderH"></i> Charlotte Pamer-Wieser  </a> </li> </ul> </div> </div> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="1" data-hidewhencollapse="" data-class=""> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="8d608633-040d-4de9-994b-5dd9f17f525a" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Executive Committee" href="/about/executive-committee" > <i class="borderH"></i> Executive Committee  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="027dfb25-c2f0-4c80-8102-e479fafbe2fa" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Vasant (Vas) Narasimhan" href="/about/executive-committee/vasant-narasimhan" > <i class="borderH"></i> Vasant (Vas) Narasimhan  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d55f4488-5625-4ef3-9b1a-95dc4ae040ba" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Shreeram Aradhye" href="/about/executive-committee/shreeram-aradhye" > <i class="borderH"></i> Shreeram Aradhye  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="630f0061-03e8-4695-8c52-f015073f56b8" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Victor Bulto" href="/about/executive-committee/victor-bulto" > <i class="borderH"></i> Victor Bulto  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="29d231e2-2520-49dc-8aef-345beabb6389" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Aharon (Ronny) Gal" href="/about/executive-committee/aharon-ronny-gal-phd" > <i class="borderH"></i> Aharon (Ronny) Gal  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="033eb7ec-0138-4432-8bbe-180e342e6824" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Karen L. Hale" href="/about/executive-committee/karen-hale" > <i class="borderH"></i> Karen L. Hale  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="1e7d1910-be8a-45e4-85cc-cd1b0dbb44fb" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patrick Horber" href="/about/executive-committee/patrick-horber-md" > <i class="borderH"></i> Patrick Horber  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="801042d7-54c5-4ce8-88f2-41554dab7ba8" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Harry Kirsch" href="/about/executive-committee/harry-kirsch" > <i class="borderH"></i> Harry Kirsch  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="3bf20f58-8f5c-44e3-aaf1-b27f5803cd15" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Rob Kowalski" href="/about/executive-committee/rob-kowalski" > <i class="borderH"></i> Rob Kowalski  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="091f6f48-15f9-4a78-a8ee-aa1a21cff9be" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Steffen Lang" href="/about/executive-committee/steffen-lang" > <i class="borderH"></i> Steffen Lang  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="3f3f29a2-25a7-48d1-b84c-1d12e8f86eae" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Fiona Marshall" href="/about/executive-committee/fiona-marshall" > <i class="borderH"></i> Fiona Marshall  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="127cba96-cf6e-4cf9-9b77-bf2ee6bb3d3c" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Klaus Moosmayer" href="/about/executive-committee/klaus-moosmayer" > <i class="borderH"></i> Klaus Moosmayer  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="3c2bf703-a1fb-4fa2-ae90-7410406d5d47" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Lutz Hegemann" href="/about/executive-committee/lutz-hegemann" > <i class="borderH"></i> Lutz Hegemann  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="e1cdcea7-01ff-4bf8-8daa-0c1487e40936" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Kees Roks" href="/about/executive-committee/kees-roks" > <i class="borderH"></i> Kees Roks  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="c3132e5e-34f5-405f-bc1d-dde1aeba6a1f" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Michelle Weese" href="/about/executive-committee/michelle-weese" > <i class="borderH"></i> Michelle Weese  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="096fb3a4-ec1f-46be-b5f9-a60c45126afd" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Products" href="/about/products" > <i class="borderH"></i> Products  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="5fd00882-aad4-4fd1-ab48-9b55d38e8806" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Therapeutic areas" href="/about/therapeutic-areas" > <i class="borderH"></i> Therapeutic areas  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="9cfc248c-6cec-4bd1-85d4-74d79a5c4347" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Cardiovascular, renal and metabolic" href="/about/therapeutic-areas/cardiovascular-renal-and-metabolic" > <i class="borderH"></i> Cardiovascular, renal and metabolic  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="b0516319-8831-41b4-875e-ae70773aad07" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Immunology" href="/about/therapeutic-areas/immunology" > <i class="borderH"></i> Immunology  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d9224d7b-e06b-42b7-8bfd-f6de30abc945" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Neuroscience" href="/about/therapeutic-areas/neuroscience" > <i class="borderH"></i> Neuroscience  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="f30e1f2d-03a0-40eb-ac26-3a1d369f2427" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Oncology" href="/about/therapeutic-areas/oncology" > <i class="borderH"></i> Oncology  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="618ec5d2-5c5b-4c95-a8d9-bf4d287326fb" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="People and culture" href="/about/people-and-culture" > <i class="borderH"></i> People and culture  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="6debbe89-8521-42a3-9d40-969cb6a80e4d" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Inclusion" href="/about/inclusion" > <i class="borderH"></i> Inclusion  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="62491321-3e2f-4649-be3f-cdece1e2b7b5" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Promoting inclusion" href="/about/inclusion/promoting-inclusion" > <i class="borderH"></i> Promoting inclusion  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="871b0037-dce8-4a39-b3a5-71cd3dfce0ce" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Building belonging" href="/about/inclusion/building-belonging" > <i class="borderH"></i> Building belonging  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="a6f60f22-9c9f-4795-8109-ffdbf766d628" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Parental leave" href="/about/inclusion/parental-leave" > <i class="borderH"></i> Parental leave  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="b54ca17e-275f-42f6-b694-579939130c0a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis Gene Therapies" href="/about/novartis-gene-therapies" > <i class="borderH"></i> Novartis Gene Therapies  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="bc8aaad3-0e6e-480f-b7c9-aff38f81d003" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Manufacturing" href="/about/manufacturing" > <i class="borderH"></i> Manufacturing  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="b361cacc-02eb-44d1-b4ee-f21fc79743bb" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Quality" href="/about/quality" > <i class="borderH"></i> Quality  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="1d614ba6-1ff6-4192-92cf-6325a8c548f0" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Audit program" href="/about/quality/audit-program" > <i class="borderH"></i> Audit program  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="8b48ca89-4db0-4f8d-97cd-876a3a347332" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis quality management system (QMS)" href="/about/quality/novartis-quality-management-system-qms" > <i class="borderH"></i> Novartis quality management system (QMS)  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="1c43d8d3-d2b2-46b0-bd57-e2b1fe5a0077" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Product and patient safety training" href="/about/quality/product-and-patient-safety-training" > <i class="borderH"></i> Product and patient safety training  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="901cc6b8-10c6-49ee-83a1-a3316ea720c5" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Regulatory inspections" href="/about/quality/regulatory-inspections" > <i class="borderH"></i> Regulatory inspections  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="ed811750-e3f2-459c-9eea-8a7e05ae4735" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Product recalls" href="/about/quality/product-recalls" > <i class="borderH"></i> Product recalls  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="516667ea-93b2-49c2-aae1-77c8b5b1b3dd" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Third-party suppliers" href="/about/quality/third-party-suppliers" > <i class="borderH"></i> Third-party suppliers  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="23da37d2-b27b-4c8c-9b93-9b1bc88b131d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Awards and recognition" href="/about/awards-and-recognition" > <i class="borderH"></i> Awards and recognition  </a> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_aboutusmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-aboutusmegamenu" data-block-plugin-id="block_content:b3e5f886-7b1e-4657-9cdf-7edd29b61713" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/mother-daughter-cuddling-on-a-bed-kid-room-menu.jpg.webp?itok=KmIUz5U9" alt="Mother and daughter cuddling on a bed in a kids room" title="Mother and daughter cuddling on a bed in a kids room"/> </div> <div class="section-content"> <p>About</p> </div> <div class="section-description" > <p><span lang="EN-GB">Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.</span><span lang="EN-GB"></span></p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="46c98121-e544-4ac9-bc64-a92da86975ca" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patients and caregivers" href="/patients-and-caregivers" > <i class="borderH"></i> Patients and caregivers  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="8ddfa590-bb8f-4fe8-aaef-d9cf3f71c079" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis commitment to patients and caregivers" href="/patients-and-caregivers/novartis-commitment-patients-and-caregivers" > <i class="borderH"></i> Novartis commitment to patients and caregivers  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="01e98576-f3e6-4602-bfc8-c6e2bcd14487" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Diseases" href="/diseases" > <i class="borderH"></i> Diseases  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="0617991d-c0cc-4cdf-a385-b0656846b215" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patient organization funding" href="/investors/reporting-and-transparency-hub/patient-organization-funding" > <i class="borderH"></i> Patient organization funding  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="a60978a2-5d32-4919-acce-3930fd343297" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patients perspectives stories" href="/news/stories/patient-perspectives" > <i class="borderH"></i> Patients perspectives stories  </a> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_pastprogramsmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-pastprogramsmegamenu" data-block-plugin-id="block_content:ed5e103c-408c-400f-b126-a637a4f8892b" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/daughter-talking-to-senior-parents-on-bench-in-park-menu.jpg.webp?itok=5-8i5oYL" alt="Adult daughter talking to her senior parents on a bench in a park" title="Adult daughter talking to her senior parents on a bench in a park"/> </div> <div class="section-content"> <p>Patients and caregivers</p> </div> <div class="section-description"> <p>Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.</p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="b4364451-6e42-439d-b9f1-488d07300db8" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Healthcare professionals" href="/healthcare-professionals" > <i class="borderH"></i> Healthcare professionals  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="11d7015e-a737-4f79-a602-094adc01004d" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Medical congresses and events" href="/healthcare-professionals/medical-congresses-and-events" > <i class="borderH"></i> Medical congresses and events  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="e226fb14-eb0b-4cab-aaac-98e862d72122" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="ASCO Annual Meeting" href="/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting" > <i class="borderH"></i> ASCO Annual Meeting  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="1fff014f-7291-4404-96eb-22f22ce3fd81" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Products" href="/about/products" > <i class="borderH"></i> Products  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="06d3fd33-3c85-4a57-b376-bc4dc5efa61a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis pipeline" href="/research-development/novartis-pipeline" > <i class="borderH"></i> Novartis pipeline  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="3760133b-2f72-4523-9a8a-37c30ce781f9" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Managed access programs" href="/healthcare-professionals/managed-access-programs" > <i class="borderH"></i> Managed access programs  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="68d8f7c4-6c65-4021-b481-9178ab65d5f1" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Zolgensma® Global Managed Access Program (gMAP)" href="/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap" > <i class="borderH"></i> Zolgensma® Global Managed Access Program (gMAP)  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="eb99b2f1-d210-4aac-b11f-f032568f0e05" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis external funding" href="/healthcare-professionals/novartis-external-funding" > <i class="borderH"></i> Novartis external funding  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="edff51ad-7a45-4230-aa14-58d570d0348a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Healthcare professional resources by country" href="/healthcare-professionals/healthcare-professional-resources-country" > <i class="borderH"></i> Healthcare professional resources by country  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="ad05952f-64fc-4e98-8e30-9c981978c572" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Investigator-initiated trials / studies" href="/healthcare-professionals/investigator-initiated-trials-studies-clinical-and-investigator-initiated-research-non-clinical" > <i class="borderH"></i> Investigator-initiated trials / studies  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="8a9e6809-1be7-43b8-9990-06c696c477ed" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis medical information" href="/healthcare-professionals/novartis-medical-information" > <i class="borderH"></i> Novartis medical information  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="8d1754ee-9fcc-4433-97a5-266f8c443bc9" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Submit medical enquiry" href="/healthcare-professionals/novartis-medical-information/submit-medical-enquiry" > <i class="borderH"></i> Submit medical enquiry  </a> </li> </ul> </div> </div> </div> </div> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_urbanpopulationhealthtoolkitmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-urbanpopulationhealthtoolkitmegamenu" data-block-plugin-id="block_content:cc0da63d-5a9d-4b5b-ab3f-409b2d874201" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2024-12/doctor-discussing-illness-with-patient-in-office.jpg.webp?itok=b4vZqx-F" alt="Doctor discussing illness with patient in an office" title="Doctor discussing illness with patient in an office"/> </div> <div class="section-content"> <p>Healthcare professionals</p> </div> <div class="section-description"> <p>Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.</p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="894d9f4b-bb45-440c-857d-7c4c4ba4e80d" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Research and development" href="/research-and-development" > <i class="borderH"></i> Research and development  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="6ace054d-fd4d-49cf-bc2a-f96f5d32797c" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Technology platforms" href="/research-and-development/technology-platforms" > <i class="borderH"></i> Technology platforms  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="cafe4feb-1070-4491-b100-5ad0b82f1f5a" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Research disease areas" href="/research-and-development/research-disease-areas" > <i class="borderH"></i> Research disease areas  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="7f315ec4-9ee6-4d7a-a663-db8753d1a136" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Cardiovascular and metabolic disease research at Novartis" href="/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis" > <i class="borderH"></i> Cardiovascular and metabolic disease research at Novartis  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="351edb8d-41b2-4017-84bf-c218dadada05" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="DAx: exploratory disease research at Novartis" href="/research-and-development/research-disease-areas/dax-exploratory-disease-research-novartis" > <i class="borderH"></i> DAx: exploratory disease research at Novartis  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="c8918731-3521-46b6-bdaf-0e4777d203df" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Global Health disease area research at Novartis" href="/research-and-development/research-disease-areas/global-health-disease-area-research-novartis" > <i class="borderH"></i> Global Health disease area research at Novartis  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="24dc4013-789b-4d6d-bc25-c284725ac3bf" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Immunology disease research at Novartis" href="/research-and-development/research-disease-areas/immunology-disease-research-novartis" > <i class="borderH"></i> Immunology disease research at Novartis  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d2871154-4542-45fe-8da6-ad33009057b0" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Neuroscience research at Novartis" href="/research-and-development/research-disease-areas/neuroscience-research-novartis" > <i class="borderH"></i> Neuroscience research at Novartis  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="3a4537ee-856e-4220-abda-a6d1a6e14d8d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Oncology research at Novartis" href="/research-and-development/research-disease-areas/oncology-research-novartis" > <i class="borderH"></i> Oncology research at Novartis  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="8a96258e-7c76-4cdf-93a2-459607e8b072" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Ophthalmology research at Novartis" href="/research-and-development/research-disease-areas/ophthalmology-research-novartis" > <i class="borderH"></i> Ophthalmology research at Novartis  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="a9c56b7d-a32e-4a62-b79f-b46ebbbf5c31" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis pipeline" href="/research-development/novartis-pipeline" > <i class="borderH"></i> Novartis pipeline  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="1ce2d660-faca-4b89-bb2e-ce3809fa5ec7" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Research collaborations" href="/research-and-development/research-collaborations" > <i class="borderH"></i> Research collaborations  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="81131598-f7aa-4ac4-aa58-6acbd22d70f7" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Collaborations" href="/research-and-development/collaborations" > <i class="borderH"></i> Collaborations  </a> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_transformingpopulationhealthmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-transformingpopulationhealthmegamenu" data-block-plugin-id="block_content:2c934034-74bb-41fa-89b7-64f2cc18e7a3" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/portrait-research-scientist-cambridge.jpg.webp?itok=_1WeOYMU" alt="A female research scientist in a lab looking at a sample" title="A female research scientist in a lab looking at a sample"/> </div> <div class="section-content"> <p>Research & development</p> </div> <div class="section-description"> <p>Discover how Novartis turns breakthrough science into transformative, high-value treatments.<br> </p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="a94d478a-baf3-4580-b6a6-fe2455a6a633" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="ESG" href="/esg" > <i class="borderH"></i> ESG  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="26381651-ce68-4b2d-bd07-58862999733b" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Access" href="/esg/access" > <i class="borderH"></i> Access  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="8315bfe5-bf85-473f-8eda-04c6dd14f536" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Creating sustainable business models" href="/esg/access/creating-sustainable-business-models" > <i class="borderH"></i> Creating sustainable business models  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="91dcefd8-5ede-47b9-bab4-eb5bfd048f4c" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Value-based pricing" href="/esg/access/value-based-pricing" > <i class="borderH"></i> Value-based pricing  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d6f7add1-2357-46ed-879d-7b9d41807746" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Sub-Saharan Africa" href="/esg/access/sub-saharan-africa" > <i class="borderH"></i> Sub-Saharan Africa  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="954fe6c9-2f23-410b-ae8c-88b852292d35" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Donations" href="/esg/access/donations" > <i class="borderH"></i> Donations  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="9591d434-1032-411f-842b-a47a60490feb" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis access principles" href="/esg/access/novartis-access-principles" > <i class="borderH"></i> Novartis access principles  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="cffd27c3-ca16-4a79-acf8-14387d232ba1" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis oncology access" href="/esg/access/novartis-oncology-access" > <i class="borderH"></i> Novartis oncology access  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="ff07f33f-e40a-47d9-b363-6a8266a8fcc1" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patents and licensing" href="/esg/access/patents-and-licensing" > <i class="borderH"></i> Patents and licensing  </a> </li> </ul> </div> </div> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="1" data-hidewhencollapse="" data-class=""> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="90d5f422-ce85-43e2-aced-62198f3af8da" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Environmental sustainability" href="/esg/environmental-sustainability" > <i class="borderH"></i> Environmental sustainability  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d1e43175-0d93-40de-a4aa-961f6dd6db6a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Climate" href="/esg/environmental-sustainability/climate" > <i class="borderH"></i> Climate  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="9521ccba-18b2-4d49-98aa-a3665aec4b8a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Nature - Waste" href="/esg/environmental-sustainability/waste" > <i class="borderH"></i> Nature - Waste  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="34e517a7-3e69-4e37-ad69-b50859829c7c" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Nature - Water" href="/esg/environmental-sustainability/water" > <i class="borderH"></i> Nature - Water  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="81a141e1-e5f2-4fc4-a44d-e46fe8ef2c0c" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Ethics, risk and compliance" href="/esg/ethics-risk-and-compliance" > <i class="borderH"></i> Ethics, risk and compliance  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="97ddfe83-2a8c-4d63-a6b8-de68edf60805" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Ethical behavior" href="/esg/ethics-risk-and-compliance/ethical-behavior" > <i class="borderH"></i> Ethical behavior  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d12983bc-1e54-4673-8dda-b19b0d979f66" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Compliance" href="/esg/ethics-risk-and-compliance/compliance" > <i class="borderH"></i> Compliance  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="b97cf671-d9b0-48b0-bdea-55b7d28170f3" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Human rights" href="/esg/ethics-risk-and-compliance/human-rights" > <i class="borderH"></i> Human rights  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="44703f5e-932b-44cf-8c21-281af1f5523a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Learning and engagement" href="/esg/ethics-risk-and-compliance/learning-and-engagement" > <i class="borderH"></i> Learning and engagement  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="11c73bec-fe9f-4886-a0b5-225ac8a574a5" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Integrated risk assurance" href="/esg/ethics-risk-and-compliance/integrated-risk-assurance" > <i class="borderH"></i> Integrated risk assurance  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="5dc4ab37-743e-4b57-af0f-45abe0b13de6" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Global health" href="/esg/global-health" > <i class="borderH"></i> Global health  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="369c0a83-6a69-4ab1-9abb-69df822bc4e5" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Pandemic preparedness" href="/esg/global-health/pandemic-preparedness" > <i class="borderH"></i> Pandemic preparedness  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="c1adc084-77d6-4622-aa75-6ba8fb87cc33" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Avoidable blindness" href="/esg/global-health/avoidable-blindness" > <i class="borderH"></i> Avoidable blindness  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="e469cddb-ddc5-41c7-8af6-bead778674dd" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Chagas disease" href="/diseases/chagas-disease" > <i class="borderH"></i> Chagas disease  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="915b17d2-4d3d-4be5-b768-4c7ca4600528" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Leprosy" href="/diseases/leprosy" > <i class="borderH"></i> Leprosy  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="0400fa5c-245a-4a14-a986-83480331ca8b" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Malaria" href="/diseases/malaria" > <i class="borderH"></i> Malaria  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="ab74aff7-130a-415b-9b56-13d02edb09ce" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Sickle cell disease (SCD)" href="/diseases/sickle-cell-disease" > <i class="borderH"></i> Sickle cell disease (SCD)  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="140f2e3f-83f6-48f2-890d-877737752e29" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target="_blank"> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis Foundation" href="https://www.novartisfoundation.org/" target="_blank" > <i class="borderH"></i> Novartis Foundation  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="d5fe8b41-0832-45f6-95f1-e645ee188205" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Inclusion" href="/about/inclusion" > <i class="borderH"></i> Inclusion  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="b3d0491b-88a9-4c21-9f73-e97b0b75d7ae" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="ESG index" href="/esg/index" > <i class="borderH"></i> ESG index  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="ea83dabe-3d81-44f3-ab2f-5f6b73685a08" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Reporting and transparency hub" href="/investors/reporting-and-transparency-hub" > <i class="borderH"></i> Reporting and transparency hub  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="46f334cb-9d2b-44c5-b2fa-0572e2bcc6d5" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="ESG rating performance" href="/investors/reporting-and-transparency-hub/esg-rating-performance" > <i class="borderH"></i> ESG rating performance  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="f50a550c-73fb-4994-a492-9c2e1922d625" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Targets" href="/investors/reporting-and-transparency-hub/targets" > <i class="borderH"></i> Targets  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="98951119-f9a3-4af9-9ded-cddd6209ffbd" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Patient organization funding" href="/investors/reporting-and-transparency-hub/patient-organization-funding" > <i class="borderH"></i> Patient organization funding  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="93059280-8f92-4c29-96ce-cb57aecfdf89" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Payments to healthcare professionals" href="/investors/reporting-and-transparency-hub/payments-healthcare-professionals" > <i class="borderH"></i> Payments to healthcare professionals  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="fcdd2c6e-0dc1-4304-b3fb-f74b9d42f757" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Public policy" href="/investors/reporting-and-transparency-hub/public-policy" > <i class="borderH"></i> Public policy  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="ad472980-5736-4774-881d-3baa96f46a61" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="A living wage" href="/investors/reporting-and-transparency-hub/living-wage" > <i class="borderH"></i> A living wage  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="73f8057e-9328-42f5-a34a-3c508e5b4af0" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="A safe workplace" href="/investors/reporting-and-transparency-hub/safe-workplace" > <i class="borderH"></i> A safe workplace  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="798fcb34-acef-4d12-85b7-6dd36ae17a5c" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Animal research" href="/investors/reporting-and-transparency-hub/animal-research" > <i class="borderH"></i> Animal research  </a> </li> </ul> </div> </div> </div> </div> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_responsibilitymegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-responsibilitymegamenu" data-block-plugin-id="block_content:def911a5-1d7e-4a05-914e-6b7839ad3ec5" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2024-12/family-and-friends-party-at-home.jpg.webp?itok=fnr5p6Td" alt="Family and friends having a party at home" title="Family and friends having a party at home"/> </div> <div class="section-content"> <p>Environmental, social and governance</p> </div> <div class="section-description"> <p>Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.</p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="201d99e2-cf92-4d8f-adb4-ba5c192edb83" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Investors" href="/investors" > <i class="borderH"></i> Investors  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="6f10e0e7-0a26-48ea-b148-3c046f9d4ce1" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Event calendar" href="/investors/event-calendar" > <i class="borderH"></i> Event calendar  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="69e2984b-1146-459b-84aa-7ccfdc2ced75" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Financial data" href="/investors/financial-data" > <i class="borderH"></i> Financial data  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="5c36695f-167f-4eab-ae6a-2edd46e4d526" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis annual results" href="/investors/financial-data/annual-results" > <i class="borderH"></i> Novartis annual results  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="f0a69fcd-f320-40f9-a4e2-550b86968652" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis quarterly results" href="/investors/financial-data/quarterly-results" > <i class="borderH"></i> Novartis quarterly results  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d2fffbb6-f910-450d-8a3c-1223e7643a90" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Novartis SEC filings" href="/investors/financial-data/sec-filings" > <i class="borderH"></i> Novartis SEC filings  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="5d19036c-9879-4731-86c3-ec30d752142d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Product sales" href="/investors/financial-data/product-sales" > <i class="borderH"></i> Product sales  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="e4e13ec5-8334-4625-bbf0-f451aa1fc1d4" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Fixed-income securities" href="/investors/financial-data/fixed-income-securities" > <i class="borderH"></i> Fixed-income securities  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="bcd5e621-04f8-4f2e-9f00-9cd05d7a219d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Expected currency impact" href="/investors/financial-data/expected-currency-impact" > <i class="borderH"></i> Expected currency impact  </a> </li> </ul> </div> </div> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="1" data-hidewhencollapse="" data-class=""> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="37fd921f-a2cc-4263-8765-d64cad580fce" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Share data and analysis" href="/investors/share-data-and-analysis" > <i class="borderH"></i> Share data and analysis  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="c4cc34fb-a116-43fd-a4a9-e4fa5d5c3a03" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Share monitor" href="/investors/share-data-and-analysis/share-monitor" > <i class="borderH"></i> Share monitor  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="2d090535-e94a-458f-a06c-21f66a42b265" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Dividend information" href="/investors/share-data-and-analysis/dividend-information" > <i class="borderH"></i> Dividend information  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d7a02fb9-9b0c-40f3-aa13-5f136aa5da47" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Share ownership" href="/investors/share-data-and-analysis/share-ownership" > <i class="borderH"></i> Share ownership  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="2e2c25d5-021f-4fc1-a86c-24bb13390eec" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Share overview" href="/investors/share-data-and-analysis/share-overview" > <i class="borderH"></i> Share overview  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="c31d0c14-3199-48d2-ab16-b95651d164e8" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Return on investment calculator" href="/investors/share-data-and-analysis/return-investment-calculator" > <i class="borderH"></i> Return on investment calculator  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="c6f0c9b4-6ce2-4b61-85ef-659eed01c37a" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Shareholder information" href="/investors/shareholder-information" > <i class="borderH"></i> Shareholder information  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="28ebce69-77cc-4698-a768-3062a057db4d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="General Meetings" href="/investors/shareholder-information/general-meetings" > <i class="borderH"></i> General Meetings  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="f2a14444-5203-471c-aacc-0d05da5b8c70" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="American Depositary Receipts (ADR)" href="/investors/shareholder-information/american-depositary-receipts-adr" > <i class="borderH"></i> American Depositary Receipts (ADR)  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="eb620df0-894e-4dac-a05c-a7d72b632212" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Share buyback" href="/investors/shareholder-information/share-buy-back" > <i class="borderH"></i> Share buyback  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d4b256fe-cb4c-49d8-9209-9d888a9a13d4" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Frequently asked questions" href="/investors/shareholder-information/frequently-asked-questions" > <i class="borderH"></i> Frequently asked questions  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="d962b090-8a3c-4abb-9709-6db65a662dad" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Company overview" href="/investors/company-overview" > <i class="borderH"></i> Company overview  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="b7de0e83-6d6e-469a-b092-ef49e87c6173" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Corporate governance" href="/investors/company-overview/corporate-governance" > <i class="borderH"></i> Corporate governance  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="4f7a068e-3b19-4392-b2a3-1bafd341dbb0" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Reporting and transparency hub" href="/investors/reporting-and-transparency-hub" > <i class="borderH"></i> Reporting and transparency hub  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="1776f4d7-3ce7-427b-af6a-a1a926e8ae38" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Reporting archive" href="/investors/reporting-and-transparency-hub/reporting-archive" > <i class="borderH"></i> Reporting archive  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="78ff13c1-d69a-41fc-af41-23d8a50fc7e3" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="ESG rating performance" href="/investors/reporting-and-transparency-hub/esg-rating-performance" > <i class="borderH"></i> ESG rating performance  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="5a27516c-a817-4c3c-80b9-13463c1e36ff" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Publications order form" href="/news/stay-up-to-date" > <i class="borderH"></i> Publications order form  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="a948a94d-2ea8-4706-9ce1-e490feabb5f0" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="ESG" href="/esg" > <i class="borderH"></i> ESG  </a> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_investorsmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-investorsmegamenu" data-block-plugin-id="block_content:40d37383-0417-45b2-b93d-7c92ad1239c8" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/lp-investors-business-woman-with-laptop-on-sofa-menu.jpg.webp?itok=ipyWZ-o1" alt="Business woman working on her laptop in a bright atmosphere" title="Business woman working on her laptop in a bright atmosphere"/> </div> <div class="section-content"> <p>Investors</p> </div> <div class="section-description"> <p>Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.</p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu active active-trail" data-level="0" data-element-type="we-mega-menu-li" data-id="e96c052b-48ef-45c2-8441-0048902a0503" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="News" href="/news" > <i class="borderH"></i> News  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="77139fde-2f81-4069-986e-16256e456ee3" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="News archive " href="/news/news-archive" > <i class="borderH"></i> News archive   </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="a55b8608-2b1d-4e87-84a6-54109db3e383" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title=" Media library " href="/news/media-library" > <i class="borderH"></i> Media library   </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="9bc87ab2-c8f0-406d-8d0a-0c8130d308b0" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Stories" href="/stories" > <i class="borderH"></i> Stories  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="bb30b0bf-4e53-4498-abf4-5f2af6213d70" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Subscribe" href="/news/stay-up-to-date" > <i class="borderH"></i> Subscribe  </a> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="9ac2c8c4-c900-4c54-b986-742b1e39a4da" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Events" href="/events" > <i class="borderH"></i> Events  </a> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_newsmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-newsmegamenu" data-block-plugin-id="block_content:91ccd10e-94a7-4f98-aecb-b1eeebed854d" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/news-hero-menu.jpg.webp?itok=STu25KS9" alt="Overhead view of a meeting room with people in the foreground and screens in the background" title="Overhead view of a meeting room with people in the foreground and screens in the background"/> </div> <div class="section-content"> <p>News</p> </div> <div class="section-description"> <p>Information for journalists including media releases, statements, stories, multimedia resources and more.</p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="0" data-element-type="we-mega-menu-li" data-id="b9476fdb-6b14-433a-830b-f5ebc298d9fc" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Careers" href="/careers" > <i class="borderH"></i> Careers  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="1"> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="493d959d-989d-4f92-b85b-c8820e398350" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Career search" href="/careers/career-search" > <i class="borderH"></i> Career search  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="9ca17d45-8003-4753-85c3-efb78d95d9bc" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Our business functions" href="/careers/our-business-functions" > <i class="borderH"></i> Our business functions  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="955ebc38-8cf7-4f7c-8ea4-0d1ce9f28af3" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Careers in research and development" href="/careers/our-business-functions/careers-research-and-development" > <i class="borderH"></i> Careers in research and development  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="cf5c3360-e899-4a31-8435-2237e78a110b" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Careers in operations" href="/careers/our-business-functions/careers-operations" > <i class="borderH"></i> Careers in operations  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="7af00596-91a4-4071-8b8e-3103fb2131d1" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Careers in commercial and sales" href="/careers/our-business-functions/careers-commercial-and-sales" > <i class="borderH"></i> Careers in commercial and sales  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="104c1785-ecc8-4538-aaeb-690288ce4e99" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Careers in global functions" href="/careers/our-business-functions/careers-global-functions" > <i class="borderH"></i> Careers in global functions  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li" data-level="1" data-element-type="we-mega-menu-li" data-id="09fc83df-1014-4cbf-aa3e-45c264879f12" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Why Novartis" href="/careers/why-novartis" > <i class="borderH"></i> Why Novartis  </a> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="fcb27731-dd22-458e-ae9f-c833ef3f1724" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Career hub" href="/careers/career-hub" > <i class="borderH"></i> Career hub  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="abce3a2b-0cc3-4853-a9ca-b5fb95059432" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target="_blank"> <i class="borderH"></i> <a class="we-mega-menu-li" title="Temporary contracts" href="https://novartis.willhire.co" target="_blank" > <i class="borderH"></i> Temporary contracts  </a> </li> </ul> </div> </div> </div> </div> </li> <li class="we-mega-menu-li dropdown-menu" data-level="1" data-element-type="we-mega-menu-li" data-id="bdad7500-215f-4e48-9486-3d3defd1642f" data-submenu="1" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Early careers" href="/careers/early-careers" > <i class="borderH"></i> Early careers  </a> <div class="we-mega-menu-submenu" data-element-type="we-mega-menu-submenu"> <span class="more_from"></span> <div class="we-mega-menu-submenu-inner"> <div class="we-mega-menu-row" data-element-type="we-mega-menu-row" data-custom-row="0"> <div class="we-mega-menu-col span12" data-element-type="we-mega-menu-col" data-width="12" data-block="" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <ul class="nav nav-tabs subul"> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="d5eec8b4-c94b-415d-ac10-5ce27732318e" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Graduates" href="/careers/early-careers/graduates" > <i class="borderH"></i> Graduates  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="76d2d493-6540-4921-a596-c92d9b264522" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Students" href="/careers/early-careers/students" > <i class="borderH"></i> Students  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="670ad935-5c00-43eb-865c-ce7e6de29c42" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="US Biomedical Research internship programs" href="/careers/early-careers/us-biomedical-research-internship-programs" > <i class="borderH"></i> US Biomedical Research internship programs  </a> </li> <li class="we-mega-menu-li" data-level="2" data-element-type="we-mega-menu-li" data-id="db9d0f2b-21e0-43d2-8ff7-22e25d7d4f8d" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Community exploration and learning lab (CELL)" href="/careers/early-careers/community-exploration-and-learning-lab-cell" > <i class="borderH"></i> Community exploration and learning lab (CELL)  </a> </li> </ul> </div> </div> </div> </div> </li> </ul> </div> <div class="we-mega-menu-col span6" data-element-type="we-mega-menu-col" data-width="6" data-block="polaris_careersmegamenu" data-blocktitle="0" data-hidewhencollapse="" data-class=""> <div class="type-of-block"><div class="block-inner"><div class="megamenu-content-block"> <div id="block-polaris-careersmegamenu" data-block-plugin-id="block_content:9ac3acd1-d4a9-41d8-9213-78c78c042c9f" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/two-business-people-mega-menu.jpg.webp?itok=hwenfnKh" alt="Two business people" title="Two business people"/> </div> <div class="section-content"> <p>Careers</p> </div> <div class="section-description"> <p>Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.</p> </div> </div> </div> </div></div> </div> </div> </div> </div> </li> <li class="we-mega-menu-li single-item" data-level="0" data-element-type="we-mega-menu-li" data-id="34e92e3d-e329-4ef0-9873-3907b8078073" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Clinical trials" href="/clinicaltrials" > <i class="borderH"></i> Clinical trials  </a> </li> <li class="we-mega-menu-li single-item" data-level="0" data-element-type="we-mega-menu-li" data-id="28151ec8-c498-463d-a049-b378d197fb22" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Partnering" href="/partnering" > <i class="borderH"></i> Partnering  </a> </li> <li class="we-mega-menu-li single-item" data-level="0" data-element-type="we-mega-menu-li" data-id="d981c94a-9779-4061-aede-0b451d54bf4a" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Supplier portal" href="/supplier-portal" > <i class="borderH"></i> Supplier portal  </a> </li> <li class="we-mega-menu-li single-item" data-level="0" data-element-type="we-mega-menu-li" data-id="bcc5c263-1e1e-4428-94cb-5da657ae2939" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target="_blank"> <i class="borderH"></i> <a class="we-mega-menu-li" title="Report side effects" href="/report" target="_blank" > <i class="borderH"></i> Report side effects  </a> </li> <li class="we-mega-menu-li single-item" data-level="0" data-element-type="we-mega-menu-li" data-id="1ed1ae55-fdcc-473f-aef3-8dd33599ae10" data-submenu="0" data-group="0" data-class="" data-icon="" data-caption="" data-alignsub="" data-target=""> <i class="borderH"></i> <a class="we-mega-menu-li" title="Contacts" href="/contacts" > <i class="borderH"></i> Contacts  </a> </li> </ul> </div> </nav> <div class="we-mega-right"><div class="megamenu-content-block"> <div id="block-megamainblock" data-block-plugin-id="block_content:ecf95396-8c22-4ca8-a54d-a59f2ca66941" class="block-content-mega_menu"> <div class="section-image"> <img src="/sites/novartis_com/files/styles/image_mega_menu/public/2023-11/grandmother-mother-and-daughter-smilling-and-laughing-on-beach-menu.jpg.webp?itok=xtSMUGvg" alt="Grandmother, mother and daughter smiling and laughing on a beach" title="Grandmother, mother and daughter smiling and laughing on a beach"/> </div> <div class="section-content"> <p>Home</p> </div> <div class="section-description"> <p>Working together, we can reimagine medicine to improve and extend people’s lives.</p> </div> </div> </div> </div> </div> </div> </div> </li> </ul> </div> </div> </nav> </div> </header> </div> <div id="main-wrapper" class="layout-main-wrapper clearfix"> <div class="highlighted"> <div class="container section clearfix"> <div data-drupal-messages-fallback class="hidden"></div> </div> </div> <div class="field field--name-field-header field--type-entity-reference-revisions field--label-above"> <div class="field__label">Header</div> <div class='field__items'> <div class="field__item"> <div class="paragraph slider_banner_custom paragraph--type--banner paragraph--view-mode--default left-alignment full_width_image"> <div id="paragraph--399441" class="carousel slide " data-interval="6000" data-bs-ride="carousel" data-pause="true" > <div class="carousel-inner"> <div class="large_font shape_2 deep_blue_no_shade title-visible description-visible full_width_image_item carousel-item active left-alignment "> <div class="slider_inner--wrapper"> <div class="carousel_img_video_image"> <div class="field field--name-field-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/sites/novartis_com/files/styles/banner_full_width_image_desktop_large/public/2024-12/news-hero-v2.jpg.webp?itok=lbAS8iiH 1x" media="(min-width: 1441px)" type="image/webp" width="1920" height="1080"/> <source srcset="/sites/novartis_com/files/styles/banner_full_width_image_desktop/public/2024-12/news-hero-v2.jpg.webp?itok=eXf8VZI5 1x" media="(min-width: 769px) and (max-width: 1440px)" type="image/webp" width="1440" height="810"/> <source srcset="/sites/novartis_com/files/styles/banner_full_width_image_tablet/public/2024-12/news-hero-v2.jpg.webp?itok=pQ7UlhMy 1x" media="(min-width: 500px) and (max-width: 768px)" type="image/webp" width="768" height="432"/> <source srcset="/sites/novartis_com/files/styles/banner_image_mobile_portrait/public/2024-12/news-hero-v2.jpg.webp?itok=MfDxjEP3 1x" media="(min-width: 321px) and (max-width: 499px)" type="image/webp" width="415" height="280"/> <source srcset="/sites/novartis_com/files/styles/banner_full_width_image_mobile/public/2024-12/news-hero-v2.jpg.webp?itok=p6AEjnuX 1x" media="(max-width: 320px)" type="image/webp" width="320" height="286"/> <img loading="lazy" src="/sites/novartis_com/files/styles/banner_full_width_image_mobile_portrait/public/2024-12/news-hero-v2.jpg.webp?itok=Le2jbXLf" width="500" height="286" alt="Overhead view of a meeting room with people in the foreground and screens in the background" title="Overhead view of a meeting room with people in the foreground and screens in the background" typeof="foaf:Image" /> </picture> </div> </div> <div class="slider-content-right-full-bleed"> </div> </div> <div class="carousel_variant"> <div class="slider-content-left"> <div class="slider_inner--wrapper " > <h1 class="h1 " > Newsroom </h1> <p class="carousel_desc">News and more from the frontiers of medicine.</p> </div> </div> </div> </div> </div> <button class="banner-scroll-arrows"></button> </div> </div> </div> </div> </div> <section class="row region region-hero-banner"> </section> <div id="main" class="container-fluid custom_width"> <div class="row row-offcanvas row-offcanvas-left clearfix"> <div class="container"> <div class="main-content col order-last col-md-12 column-full" id="content"> <section class="section"> <div id="block-polaris-content" data-block-plugin-id="system_main_block" class="block block-system block-system-main-block"> <div class="content"> <article about="/news" class="node node--type-landing-page node--view-mode-full clearfix"> <header> </header> <div class="node__content clearfix"> <div class="page_content"> <div class="row content_middle"> <div class="col-sm-12 content_left_side"> <div class="field_body_txt "> <div class="field field--name-field-body field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--rich-text-content paragraph--view-mode--default"> <div class="clearfix text-formatted field field--name-field-content field--type-text-with-summary field--label-hidden field__item"><p>Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.</p></div> </div> </div> <div class="field__item"> <div class="newsroom-pager"> <div class="views-exposed-form block block-views block-views-exposed-filter-blocknews-archive-page-1 container" data-drupal-selector="views-exposed-form-news-archive-page-1" id="block-polaris-exposedformnews-archivepage-1" data-block-plugin-id="views_exposed_filter_block:news_archive-page_1"> <div> <form action="/news/news-archive" method="get" id="views-exposed-form-news-archive-page-1" accept-charset="UTF-8"> <div class="form-row arctic-exposed-form-filter"> <div class="js-form-item js-form-type-textfield form-type-textfield js-form-item-search-api-fulltext form-item-search-api-fulltext form-no-label mb-3"> <div> <input placeholder="Search News" data-drupal-selector="edit-search-api-fulltext" type="text" id="edit-search-api-fulltext" name="search_api_fulltext" value="" size="30" maxlength="128" class="form-text form-control arc-input"/> </div> </div> <div class="date-range-element"> <div class="date-range-filter-head" tabindex="0" aria-controls="date-range-element" aria-haspopup="listbox" aria-labelledby="date-range-element" role="combobox" aria-expanded="false" aria-autocomplete="none"> Date Range </div> </div> <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper mb-3" id="edit-actions--8"><div> <input data-drupal-selector="edit-submit-news-archive" type="submit" id="edit-submit-news-archive" value="Search" class="button js-form-submit form-submit btn btn-primary form-control arc-input"/> </div> </div> <div class="js-form-item js-form-type-select form-type-select js-form-item-type form-item-type form-no-label mb-3"> <div> <select data-drupal-selector="edit-type" id="edit-type" name="type" class="form-select"><option value="All" selected="selected">- Any -</option><option value="external_news">In The News</option><option value="media_release">Media Release</option><option value="news">Featured News</option><option value="story_page">Story</option></select></div> </div> <div class="js-form-item js-form-type-entity-autocomplete form-type-entity-autocomplete js-form-item-news-filters form-item-news-filters mb-3"> <label for="edit-news-filters--7">News Type Filters</label> <div> <input data-drupal-selector="edit-news-filters" class="form-autocomplete form-text form-control arc-input" data-autocomplete-path="/entity_reference_autocomplete/taxonomy_term/default/oY3CW2jnNwT8kkQdIVsVo1krCy-X5kI3_udVcktC_hU" type="text" id="edit-news-filters--7" name="news_filters" value="" size="60" maxlength="128"/> </div> </div> <div class="js-form-item js-form-type-select form-type-select js-form-item-language form-item-language mb-3"> <label for="edit-language">Language</label> <div> <select data-drupal-selector="edit-language" id="edit-language" name="language" class="form-select"><option value="All" selected="selected">- Any -</option><option value="4176">English</option><option value="4186">German</option><option value="4181">French</option></select></div> </div> <div class="js-form-item js-form-type-date form-type-date js-form-item-start-date form-item-start-date mb-3"> <label for="edit-start-date">Start Date</label> <div> <input type="date" data-drupal-selector="edit-start-date" id="edit-start-date" name="start_date" value="" size="30" class="form-date form-control arc-input"/> </div> </div> <div class="js-form-item js-form-type-date form-type-date js-form-item-end-date form-item-end-date mb-3"> <label for="edit-end-date">End Date</label> <div> <input type="date" data-drupal-selector="edit-end-date" id="edit-end-date" name="end_date" value="" size="30" class="form-date form-control arc-input"/> </div> </div> </div> </form> </div> </div> </div> <div class="mobile-tab-dropdown news-room-container clearfix"> <div class="active-quick-tab default-selected-quick-tab"><span class="search-arrow"></span></div> <ul class="nav nav-tabs biography-tabs" id="newsRoom-" role="tablist"> <li class="nav-item"> <a class="nav-link active" data-bs-toggle="tab" href="#tab-all">All</a> </li> <li class="nav-item"> <a class="nav-link " data-bs-toggle="tab" href="#tab-media-releases">Media Releases</a> </li> <li class="nav-item"> <a class="nav-link " data-bs-toggle="tab" href="#tab-key-releases">Key Releases</a> </li> <li class="nav-item"> <a class="nav-link " data-bs-toggle="tab" href="#tab-featured-news">Featured News</a> </li> <li class="nav-item"> <a class="nav-link " data-bs-toggle="tab" href="#tab-statements">Statements</a> </li> <li class="nav-item"> <a class="nav-link " data-bs-toggle="tab" href="#tab-pulse-updates">Pulse Updates</a> </li> <li class="nav-item"> <a class="nav-link " data-bs-toggle="tab" href="#tab-stories">Stories</a> </li> </ul> <div class="tab-content news-room-tabs-content px-0" id="newsRoomTabContent-"> <div class="tab-pane active" id="tab-all" aria-labelledby="All-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/news/media-releases/novartis-bolsters-late-stage-cardiovascular-pipeline-agreement-acquire-anthos-therapeutics-usd-925-million-upfront"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-02-11T07:15:00Z" class="datetime">Feb 11, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront</span></h3> <div class="views-field views-field-body"><span class="field-content">Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-continues-strong-momentum-sales-growth-margin-expansion-reaches-key-innovation-milestones-2024"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-31T07:00:00Z" class="datetime">Jan 31, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LRFull yearNet sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-setzt-die-starke-umsatzdynamik-mit-margenerhohungen-fort-und-erreicht-2024-wichtige-meilensteine-bei-innovationen"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-31T07:00:00Z" class="datetime">Jan 31, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis setzt die starke Umsatzdynamik mit Margenerhöhungen fort und erreicht 2024 wichtige Meilensteine bei Innovationen</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad-hoc-Mitteilung gemäss Art. 53 KRGeschäftsjahrDer Nettoumsatz wuchs um +12% (kWk1, +11% USD), das operative Kernergebnis1 verbesserte sich um +22% (kWk, +19% USD)Das Umsatzwachstum…</span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-presentation-jp-morgan-healthcare-conference-2025"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-14T10:00:00Z" class="datetime">Jan 14, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis presentation at J.P. Morgan Healthcare Conference 2025</span></h3> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-entresto-us-patent-upheld-us-court-appeals"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-13T07:15:00Z" class="datetime">Jan 13, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Entresto® US patent upheld by US Court of Appeals</span></h3> <div class="views-field views-field-body"><span class="field-content">Basel, January 13, 2025 – Novartis is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto® (sacubitril/valsartan) combination…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-intrathecal-onasemnogene-abeparvovec-phase-iii-study-meets-primary-endpoint-children-and-young-adults-sma"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-30T06:45:00Z" class="datetime">Dec 30, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-distant-recurrence-broad-population-patients-early-breast-cancer"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-10T15:00:00Z" class="datetime">Dec 10, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer</span></h3> <div class="views-field views-field-body"><span class="field-content">Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/longer-term-data-novartis-scemblix-reinforce-superior-efficacy-favorable-safety-and-tolerability-profile-adults-newly-diagnosed-cml"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-08T18:30:00Z" class="datetime">Dec 08, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML</span></h3> <div class="views-field views-field-body"><span class="field-content">Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs (74.1% vs. 52%) and vs. imatinib alone (76.2% vs. 47.1%), meeting both ASC4FIRST 96-week key…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/new-phase-iiib-data-shows-novartis-fabhalta-improved-hemoglobin-levels-adult-patients-paroxysmal-nocturnal-hemoglobinuria-who-switched-from-anti-c5-therapy"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-06T07:15:00Z" class="datetime">Dec 06, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">New Phase IIIB data shows Novartis Fabhalta® improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy </span></h3> <div class="views-field views-field-body"><span class="field-content">In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who were…</span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-bolsters-neuroscience-pipeline-licensing-ptc518-huntingtons-disease"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-02T13:00:00Z" class="datetime">Dec 02, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington’s disease</span></h3> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-kisqali-receives-european-commission-approval-broad-population-patients-hrher2-early-breast-cancer-high-risk-recurrence"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-27T07:15:00Z" class="datetime">Nov 27, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Kisqali® receives European Commission approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence</span></h3> <div class="views-field views-field-body"><span class="field-content">Approval is based on Phase III NATALEE data showing Kisqali® (ribociclib) plus adjuvant endocrine therapy (ET) demonstrated clinically meaningful invasive disease-free survival (iDFS) benefit in…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-highlights-new-96-week-results-from-phase-iii-scemblix-asc4first-trial-ash-and-late-breaking-analysis-from-phase-iii-kisqali-natalee-trial-sabcs"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-25T07:15:00Z" class="datetime">Nov 25, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis highlights new 96-week results from Phase III Scemblix® ASC4FIRST trial at ASH and late-breaking analysis from Phase III Kisqali® NATALEE trial at SABCS</span></h3> <div class="views-field views-field-body"><span class="field-content">Longer-term 96-week results from Scemblix® ASC4FIRST Phase III study in first-line Ph+ CML-CP to be presented following recent FDA approval based on 48-week data Late-breaking Kisqali®* 4-year…</span></div> </a> </li> </ul> </div> </div> </div> </div> <div class="tab-pane " id="tab-media-releases" aria-labelledby="Media Releases-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/news/media-releases/novartis-bolsters-late-stage-cardiovascular-pipeline-agreement-acquire-anthos-therapeutics-usd-925-million-upfront"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-02-11T07:15:00Z" class="datetime">Feb 11, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront</span></h3> <div class="views-field views-field-body"><span class="field-content">Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-continues-strong-momentum-sales-growth-margin-expansion-reaches-key-innovation-milestones-2024"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-31T07:00:00Z" class="datetime">Jan 31, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LRFull yearNet sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-setzt-die-starke-umsatzdynamik-mit-margenerhohungen-fort-und-erreicht-2024-wichtige-meilensteine-bei-innovationen"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-31T07:00:00Z" class="datetime">Jan 31, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis setzt die starke Umsatzdynamik mit Margenerhöhungen fort und erreicht 2024 wichtige Meilensteine bei Innovationen</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad-hoc-Mitteilung gemäss Art. 53 KRGeschäftsjahrDer Nettoumsatz wuchs um +12% (kWk1, +11% USD), das operative Kernergebnis1 verbesserte sich um +22% (kWk, +19% USD)Das Umsatzwachstum…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-entresto-us-patent-upheld-us-court-appeals"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-13T07:15:00Z" class="datetime">Jan 13, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Entresto® US patent upheld by US Court of Appeals</span></h3> <div class="views-field views-field-body"><span class="field-content">Basel, January 13, 2025 – Novartis is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto® (sacubitril/valsartan) combination…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-intrathecal-onasemnogene-abeparvovec-phase-iii-study-meets-primary-endpoint-children-and-young-adults-sma"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-30T06:45:00Z" class="datetime">Dec 30, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-distant-recurrence-broad-population-patients-early-breast-cancer"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-10T15:00:00Z" class="datetime">Dec 10, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer</span></h3> <div class="views-field views-field-body"><span class="field-content">Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/longer-term-data-novartis-scemblix-reinforce-superior-efficacy-favorable-safety-and-tolerability-profile-adults-newly-diagnosed-cml"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-08T18:30:00Z" class="datetime">Dec 08, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML</span></h3> <div class="views-field views-field-body"><span class="field-content">Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs (74.1% vs. 52%) and vs. imatinib alone (76.2% vs. 47.1%), meeting both ASC4FIRST 96-week key…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/new-phase-iiib-data-shows-novartis-fabhalta-improved-hemoglobin-levels-adult-patients-paroxysmal-nocturnal-hemoglobinuria-who-switched-from-anti-c5-therapy"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-06T07:15:00Z" class="datetime">Dec 06, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">New Phase IIIB data shows Novartis Fabhalta® improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy </span></h3> <div class="views-field views-field-body"><span class="field-content">In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who were…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-kisqali-receives-european-commission-approval-broad-population-patients-hrher2-early-breast-cancer-high-risk-recurrence"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-27T07:15:00Z" class="datetime">Nov 27, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Kisqali® receives European Commission approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence</span></h3> <div class="views-field views-field-body"><span class="field-content">Approval is based on Phase III NATALEE data showing Kisqali® (ribociclib) plus adjuvant endocrine therapy (ET) demonstrated clinically meaningful invasive disease-free survival (iDFS) benefit in…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-highlights-new-96-week-results-from-phase-iii-scemblix-asc4first-trial-ash-and-late-breaking-analysis-from-phase-iii-kisqali-natalee-trial-sabcs"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-25T07:15:00Z" class="datetime">Nov 25, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis highlights new 96-week results from Phase III Scemblix® ASC4FIRST trial at ASH and late-breaking analysis from Phase III Kisqali® NATALEE trial at SABCS</span></h3> <div class="views-field views-field-body"><span class="field-content">Longer-term 96-week results from Scemblix® ASC4FIRST Phase III study in first-line Ph+ CML-CP to be presented following recent FDA approval based on 48-week data Late-breaking Kisqali®* 4-year…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-upgrades-mid-term-guidance-and-highlights-deep-pipeline-core-therapeutic-areas-drive-long-term-growth"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-21T07:00:00Z" class="datetime">Nov 21, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum in the business with 8 in-market brands with USD 3bn+ to…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-ranks-first-2024-access-medicine-index"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Media Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-19T14:00:00Z" class="datetime">Nov 19, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis ranks first in 2024 Access to Medicine Index</span></h3> <div class="views-field views-field-body"><span class="field-content">The Index spotlights Novartis leadership in research and development, and governance of access, with Novartis ranking first in these sub-topics Novartis malaria access plans, widespread registration…</span></div> </a> </li> </ul> </div> </div> </div> </div> <div class="tab-pane " id="tab-key-releases" aria-labelledby="Key Releases-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/news/media-releases/novartis-continues-strong-momentum-sales-growth-margin-expansion-reaches-key-innovation-milestones-2024"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-31T07:00:00Z" class="datetime">Jan 31, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LRFull yearNet sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-setzt-die-starke-umsatzdynamik-mit-margenerhohungen-fort-und-erreicht-2024-wichtige-meilensteine-bei-innovationen"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-31T07:00:00Z" class="datetime">Jan 31, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis setzt die starke Umsatzdynamik mit Margenerhöhungen fort und erreicht 2024 wichtige Meilensteine bei Innovationen</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad-hoc-Mitteilung gemäss Art. 53 KRGeschäftsjahrDer Nettoumsatz wuchs um +12% (kWk1, +11% USD), das operative Kernergebnis1 verbesserte sich um +22% (kWk, +19% USD)Das Umsatzwachstum…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-intrathecal-onasemnogene-abeparvovec-phase-iii-study-meets-primary-endpoint-children-and-young-adults-sma"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-30T06:45:00Z" class="datetime">Dec 30, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-upgrades-mid-term-guidance-and-highlights-deep-pipeline-core-therapeutic-areas-drive-long-term-growth"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-21T07:00:00Z" class="datetime">Nov 21, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum in the business with 8 in-market brands with USD 3bn+ to…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-scemblix-fda-approved-newly-diagnosed-cml-offering-superior-efficacy-and-favorable-safety-and-tolerability-profile"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-10-29T20:03:58Z" class="datetime">Oct 29, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR Scemblix, a new first-line option for adults with CML, is first to show superior efficacy and favorable safety and tolerability profile in a Phase III…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-continues-strong-momentum-q3-10-sales-growth-20-core-operating-income-growth-and-important-innovation-milestones-raises-fy-2024-guidance"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-10-29T07:00:00Z" class="datetime">Oct 29, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis continues strong momentum in Q3 with 10% sales growth, 20% core operating income growth, and important innovation milestones; raises FY 2024 guidance</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LRQ3 net sales grew +10% (cc1, +9% USD) with core operating income up +20% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-setzt-die-starke-dynamik-im-dritten-quartal-fort-mit-steigerungen-beim-umsatz-10-und-operativen-kernergebnis-20-sowie-wichtigen-innovationsmeilensteinen-prognose-fur-2024-angehoben"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-10-29T07:00:00Z" class="datetime">Oct 29, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis setzt die starke Dynamik im dritten Quartal fort mit Steigerungen beim Umsatz (+10%) und operativen Kernergebnis (+20%) sowie wichtigen Innovationsmeilensteinen; Prognose für 2024 angehoben</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad-hoc-Mitteilung gemäss Art. 53 KRDer Nettoumsatz wuchs im dritten Quartal um +10% (kWk1, +9% USD), das operative Kernergebnis verbesserte sich um +20% (kWk, +17% USD)Das Umsatzwachstum…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/fda-approves-novartis-kisqali-reduce-risk-recurrence-people-hrher2-early-breast-cancer"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-09-17T18:55:13Z" class="datetime">Sep 17, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-receives-fda-accelerated-approval-fabhalta-iptacopan-first-and-only-complement-inhibitor-reduction-proteinuria-primary-iga-nephropathy-igan"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-08-08T01:30:00Z" class="datetime">Aug 08, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN)</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LR Fabhalta achieved a 44% proteinuria reduction from baseline in Phase III APPLAUSE-IgAN interim analysis, compared with 9% in placebo arm,…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-erzielt-im-zweiten-quartal-weiterhin-kraftige-umsatzsteigerungen-und-erhoht-die-kerngewinnmarge-gewinnprognose-fur-das-geschaftsjahr-2024-angehoben"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-07-18T07:00:00Z" class="datetime">Jul 18, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis erzielt im zweiten Quartal weiterhin kräftige Umsatzsteigerungen und erhöht die Kerngewinnmarge; Gewinnprognose für das Geschäftsjahr 2024 angehoben</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad-hoc-Mitteilung gemäss Art. 53 KRDer Nettoumsatz wuchs im zweiten Quartal um +11% (kWk1, +9% USD), das operative Kernergebnis verbesserte sich um +19% (kWk, +17% USD) Das Umsatzwachstum…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-continues-deliver-strong-sales-growth-and-core-margin-expansion-q2-raises-fy-2024-bottom-line-guidance"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-07-18T07:00:00Z" class="datetime">Jul 18, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance</span></h3> <div class="views-field views-field-body"><span class="field-content">Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+…</span></div> </a> </li> <li class="each-item"> <a href="/news/media-releases/novartis-poursuivi-au-t2-la-forte-croissance-de-son-chiffre-daffaires-et-lexpansion-de-sa-marge-core-hausse-des-previsions-de-son-resultat-operationnel-core-pour-2024"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Key Release</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-07-18T07:00:00Z" class="datetime">Jul 18, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis a poursuivi au T2 la forte croissance de son chiffre d’affaires et l’expansion de sa marge core; hausse des prévisions de son résultat opérationnel core pour 2024</span></h3> <div class="views-field views-field-body"><span class="field-content">Annonce événementielle au sens de l’art. 53 RCRésultats du deuxième trimestre (T2)Chiffre d’affaires net en hausse de +11% (tcc1, +9% USD) et du résultat opérationnel core, de +19% (tcc, +17% USD) La…</span></div> </a> </li> </ul> </div> </div> </div> </div> <div class="tab-pane " id="tab-featured-news" aria-labelledby="Featured News-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/news/official-partner-eurovision-song-contest-2025"> <div class="views-field views-field-field-featured-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-10/novartis-basel-eurovision-partnership.jpg.webp?itok=B0viK-hV" alt="Novartis is an official partner of the Eurovision Song Contest 2025" title="Novartis is an official partner of the Eurovision Song Contest 2025" width="2000" height="1333" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-10-31T10:00:00Z" class="datetime">Oct 31, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Official partner of the Eurovision Song Contest 2025</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>We’re thrilled to announce that Novartis, a proudly Swiss company, is an official partner of the Eurovision Song Contest 2025, hosted in our headquarters city of Basel, Switzerland.</p></span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-employs-creative-deal-structure-establish-borealis-biosciences-divests-legacy-chinook-site-invests-form-new-company-and-engages-rd-collaboration"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-08-22T14:00:00Z" class="datetime">Aug 22, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis employs creative deal structure to establish Borealis Biosciences – divests legacy Chinook site, invests to form new company and engages in R&D collaboration</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p><span>Novartis announced it has partnered with Versant Ventures (Versant) to form Borealis Biosciences (Borealis), an independent, discovery-stage biotechnology company based in Vancouver, Canada, focused on developing next-generation xRNA-based medicines for kidney diseases. xRNA, a core technology platform for Novartis, can target the body’s natural mRNA to modulate the production of proteins that cause disease.</span></p></span></div> </a> </li> <li class="each-item"> <a href="/news/our-next-era"> <div class="views-field views-field-field-featured-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2023-11/father-with-daugther-on-shoulders-looking-at-plant.jpg.webp?itok=0pp5J1--" alt="A father with daughter on his shoulders looking at a plant" title="A father with daughter on his shoulders looking at a plant" width="1500" height="1001" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-12-04T07:00:00Z" class="datetime">Dec 04, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Our next era</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Novartis poised to expand impact on human health as it begins next era.</p></span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-giving-volunteering-wins-accps-2023-corporate-social-impact-team-year-award"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-09-13T12:00:00Z" class="datetime">Sep 13, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis’ Giving & Volunteering wins ACCP’s 2023 Corporate Social Impact Team of the Year Award</span></h3> </a> </li> <li class="each-item"> <a href="/news/creating-positive-social-change-through-volunteering"> <div class="views-field views-field-field-featured-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2022-11/group-portrait-diverse-novartis-volunteers.jpg.webp?itok=95t7NlPH" alt="A group portrait of diverse Novartis volunteers in front of a white background, taken in the observance of International Volunteer Day 2022" title="A group portrait of diverse Novartis volunteers in front of a white background, taken in the observance of International Volunteer Day 2022" width="2000" height="646" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2022-11-29T08:30:00Z" class="datetime">Nov 29, 2022</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Creating positive social change through volunteering</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Over 1 billion people volunteer worldwide, sharing their skills and experience, providing support within their communities, and offering emergency assistance to those in need. On International Volunteer Day (December 5), we join forces with the UN to recognize the tireless work of all volunteers and the contributions that they make.</p></span></div> </a> </li> <li class="each-item"> <a href="/news/world-sight-day-2022"> <div class="views-field views-field-field-featured-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2022-10/AvoidableBlindness-herobanner_1600x800px.jpg.webp?itok=2cprnTKu" alt="Clos up photography of a boy" title="Clos up photography of a boy" width="1600" height="800" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2022-10-13T08:00:00Z" class="datetime">Oct 13, 2022</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">World Sight Day 2022: Raising awareness on the importance of eye health</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Through the Avoidable Blindness Program, Novartis is working with partners to strengthen eye health in sub-Saharan Africa.</p></span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-hematology-working-help-ensure-patients-are-getting-access-they-need"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2022-09-12T09:00:00Z" class="datetime">Sep 12, 2022</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Hematology: Working to help ensure patients are getting the access they need</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Developing treatments for blood cancers and serious blood disorders is important, but it is only part of the equation. We also need to help ensure those who may need our therapies can get them.</p></span></div> </a> </li> <li class="each-item"> <a href="/news/from-the-heart"> <div class="views-field views-field-field-featured-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2022-07/marie-france-banner-portrait.jpg.webp?itok=XyAtRaav" alt="Marie-France Tschudin, President, Innovative Medicines International & Chief Commercial Officer" title="Marie-France Tschudin, President, Innovative Medicines International & Chief Commercial Officer" width="2500" height="807" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2022-07-22T18:30:00Z" class="datetime">Jul 22, 2022</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">From the Heart</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-co-creating-impact-summit-2021"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2022-02-08T21:00:00Z" class="datetime">Feb 08, 2022</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis Co-Creating Impact Summit 2021</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.</p> </span></div> </a> </li> <li class="each-item"> <a href="/news/raising-awareness-prostate-cancer-during-movember"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2021-11-04T13:30:00Z" class="datetime">Nov 04, 2021</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Raising awareness of prostate cancer during Movember</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Despite advancements in care, prostate cancer is one of the most frequently diagnosed cancers around the world. This Movember, we’re focused on raising awareness of prostate cancer.</p> </span></div> </a> </li> <li class="each-item"> <a href="/news/sound-up"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2021-10-29T14:45:00Z" class="datetime">Oct 29, 2021</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Sound Up for Lung Cancer</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>It’s time to change the conversation. Patient inspired and community led, Sound Up aims to empower people affected by lung cancer in raising the volume to vocally self-advocate.</p> </span></div> </a> </li> <li class="each-item"> <a href="/news/world-sight-day-2021"> <div class="views-field views-field-field-featured-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2021-10/teenager-getting-eyes-tested.jpg.webp?itok=fNZhX9qf" alt="Teenager getting eyes tested" title="Teenager getting eyes tested" width="2000" height="646" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Featured News</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2021-10-14T09:00:00Z" class="datetime">Oct 14, 2021</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">World Sight Day 2021</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Novartis is working with partners around the world to help eliminate preventable visual impairment and blindness by reimagining access to eye care.</p> </span></div> </a> </li> </ul> </div> </div> </div> </div> <div class="tab-pane " id="tab-statements" aria-labelledby="Statements-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/news/novartis-statement-maximum-fair-price-entresto"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-08-15T14:36:12Z" class="datetime">Aug 15, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis statement on Maximum Fair Price for Entresto</span></h3> </a> </li> <li class="each-item"> <a href="/news/violence-against-innocent-people-runs-counter-our-work-improve-human-health"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-10-19T17:37:58Z" class="datetime">Oct 19, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Violence against innocent people runs counter to our work to improve human health </span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-condemns-terrorist-actions-against-people-israel-and-loss-innocent-lives"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-10-13T13:02:21Z" class="datetime">Oct 13, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis condemns the terrorist actions against people in Israel and loss of innocent lives</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-statement-collaboration-and-license-agreement-tislelizumab-beigene-ltd"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-09-19T14:30:46Z" class="datetime">Sep 19, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>Novartis and BeiGene, Ltd. have mutually agreed to terminate the collaboration and license agreement for tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody.</p></span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-provides-support-moroccan-earthquake-victims"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-09-13T15:22:59Z" class="datetime">Sep 13, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis provides support for Moroccan earthquake victims </span></h3> </a> </li> <li class="each-item"> <a href="/news/gt005-ppy988-development-program-geographic-atrophy"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-09-11T15:22:18Z" class="datetime">Sep 11, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">GT005 (PPY988): Development Program in Geographic Atrophy </span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-statement-filing-inflation-reduction-act-lawsuit"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-09-01T20:38:35Z" class="datetime">Sep 01, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis statement on filing of Inflation Reduction Act lawsuit</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-statement-about-entresto-sacubitrilvalsartan-selection-medicare-drug-price-negotiation-program"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-08-29T13:41:07Z" class="datetime">Aug 29, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis statement about Entresto® (sacubitril/valsartan) selection for Medicare Drug Price Negotiation Program</span></h3> </a> </li> <li class="each-item"> <a href="/news/european-commission-ec-adopts-decision-endorsing-chmp-recommendation-revoke-conditional-marketing-authorization-adakveo-crizanlizumab"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-08-04T14:19:42Z" class="datetime">Aug 04, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">European Commission (EC) adopts decision endorsing CHMP recommendation to revoke the conditional marketing authorization for Adakveo® (crizanlizumab)</span></h3> </a> </li> <li class="each-item"> <a href="/news/chmp-recommends-revoking-conditional-marketing-authorization-adakveo-crizanlizumab"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-05-26T14:03:59Z" class="datetime">May 26, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">CHMP recommends revoking the conditional marketing authorization for Adakveo® (crizanlizumab)</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-unwavering-support-one-year-from-start-war-ukraine"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-02-28T17:30:00Z" class="datetime">Feb 28, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis unwavering in support one year on from the start of the war in Ukraine</span></h3> <div class="views-field views-field-field-new-intro-text"><span class="field-content"><p>On February 24, we marked the first anniversary of the war in Ukraine. Novartis continues to condemn the ongoing conflict, while our unwavering support to those impacted continues through humanitarian aid, financial donations and critical medicines.</p> <div> <div> <div class="msocomtxt" id="_com_1"></div> </div> </div></span></div> </a> </li> <li class="each-item"> <a href="/news/novartis-releases-emergency-funding-usd-1-million-people-turkey-and-syria-and-launches-employee-donation-and-volunteering-programs"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Statement</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-02-09T13:53:41Z" class="datetime">Feb 09, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis releases emergency funding of USD 1 million for people in Turkey and Syria, and launches employee donation and volunteering programs</span></h3> </a> </li> </ul> </div> </div> </div> </div> <div class="tab-pane " id="tab-pulse-updates" aria-labelledby="Pulse Updates-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/news/novartis-presentation-jp-morgan-healthcare-conference-2025"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2025-01-14T10:00:00Z" class="datetime">Jan 14, 2025</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis presentation at J.P. Morgan Healthcare Conference 2025</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-bolsters-neuroscience-pipeline-licensing-ptc518-huntingtons-disease"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-12-02T13:00:00Z" class="datetime">Dec 02, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington’s disease</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-receives-fda-breakthrough-therapy-designation-scemblix-1l-cml"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-05-10T15:00:00Z" class="datetime">May 10, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis receives FDA Breakthrough Therapy designation for Scemblix® in 1L CML</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-implements-manufacturing-adjustments-ribociclib-ensure-alignment-latest-regulatory-standards-ebc-end-q2"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-04-09T20:32:49Z" class="datetime">Apr 09, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis implements manufacturing adjustments for ribociclib to ensure alignment with latest regulatory standards in eBC by end of Q2</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-confirms-plans-file-pluvicto-pre-taxane-label-expansion-h2-2024-based-latest-data-from-phase-iii-psmafore-study"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-04-04T16:00:00Z" class="datetime">Apr 04, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis confirms plans to file for Pluvicto® pre-taxane label expansion in H2 2024 based on latest data from Phase III PSMAfore study</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-appoints-sloan-simpson-global-head-investor-relations"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-02-16T14:30:00Z" class="datetime">Feb 16, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis appoints Sloan Simpson as Global Head of Investor Relations</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-shares-strategy-and-growth-update-jp-morgan-healthcare-conference-2024"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-01-08T17:15:00Z" class="datetime">Jan 08, 2024</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis shares strategy and growth update at J.P. Morgan Healthcare Conference 2024</span></h3> </a> </li> <li class="each-item"> <a href="/news/fda-approves-novartis-millburn-facility-us-commercial-production-pluvicto"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-04-21T17:30:00Z" class="datetime">Apr 21, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">FDA approves Novartis Millburn facility for US commercial production of Pluvicto®</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-completes-fda-filing-approval-millburn-facility-support-pluvicto-launch"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-03-02T18:00:00Z" class="datetime">Mar 02, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis completes FDA filing for approval of Millburn facility to support Pluvicto® launch</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-shares-strategy-insights-and-highlights-key-pipeline-catalysts-jp-morgan-healthcare-conference-2023"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2023-01-09T17:15:00Z" class="datetime">Jan 09, 2023</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis shares strategy insights and highlights key pipeline catalysts at JP Morgan Healthcare Conference 2023</span></h3> </a> </li> <li class="each-item"> <a href="/news/novartis-receives-fda-fast-track-designation-branaplam-lmi070-treatment-huntingtons-disease"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2021-12-16T10:00:00Z" class="datetime">Dec 16, 2021</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">Novartis receives FDA Fast Track designation for branaplam (LMI070) for the treatment of Huntington’s Disease</span></h3> </a> </li> <li class="each-item"> <a href="/news/fda-grants-priority-review-investigational-targeted-radioligand-therapy-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc"> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Pulse Update</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2021-09-28T15:00:00Z" class="datetime">Sep 28, 2021</time> </span></span> <h3 class="views-field views-field-title"><span class="field-content">FDA grants Priority Review for investigational targeted radioligand therapy 177Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC)</span></h3> </a> </li> </ul> </div> </div> </div> </div> <div class="tab-pane " id="tab-stories" aria-labelledby="Stories-tab"> <div class="view view-news-room view-id-news_room view-display-id-block_1 arctic_grid_view arctic_over_view_toggle"> <div class="view-content"> <div class="item-list"> <ul class="whole-item"> <li class="each-item"> <a href="/stories/biologist-head-hunter"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-11/lina-borda-samper.jpg.webp?itok=Stvy_A1n" alt="Lina Borda Samper" title="Lina Borda Samper" width="1080" height="1080" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-22T09:54:27Z" class="datetime">Nov 22, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <h3 class="views-field views-field-title"><span class="field-content">Biologist to Head-hunter</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>I sometimes overlook what I’ve achieved or overcome to arrive at this point in my career. The opportunities I’ve embraced, the advice I’ve received and the heartfelt decisions I’ve made. So sharing my journey with you was an opportunity to pause and reflect, strengthening my belief that change is not always easy, but it can be very rewarding.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/addressing-unmet-needs-inherited-neuromuscular-diseases"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-11/scientists-conducting-innovative-research-experiments-nibr-labs-24.png.webp?itok=gqZDiFsl" alt="Scientists working together in a biomedical research lab." title="Scientists working together in a biomedical research lab." width="1920" height="620" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-11-21T13:00:00Z" class="datetime">Nov 21, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">Discovery</span></span> <h3 class="views-field views-field-title"><span class="field-content">Addressing unmet needs for inherited neuromuscular diseases</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>Novartis has acquired Kate Therapeutics to further enhance and strengthen our ongoing efforts to advance gene therapies for patients.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/my-journey-novartis-finding-my-purpose-and-passion"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-10/valeria-product-manager.jpg.webp?itok=sRQ7LF0J" alt="Valeria, Product Manager" title="Valeria, Product Manager" width="1000" height="667" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-10-29T12:00:00Z" class="datetime">Oct 29, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <span class="views-field views-field-field-sub-category views-field-nothing"><span class="field-content">Careers</span></span> <h3 class="views-field views-field-title"><span class="field-content">My Journey to Novartis: Finding my Purpose and Passion</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>When I first joined Novartis, I was nervous yet open to new experiences. I did not have experience in the pharmaceutical industry, and the dynamics and ways of working in marketing were completely different from what I was used to. But what sealed the deal for me was a conversation with my then manager who told me that the purpose I would feel and impact I would have would be unique. And she was right.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/negative-impact-ira-patient-access-innovative-treatments"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-08/victor-bulto-president-us-novartis-story-image-660-370.png.webp?itok=xhe3scsZ" alt="Victor Bulto, President US, Novartis" title="Victor Bulto, President US, Novartis" width="700" height="392" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-08-15T14:46:38Z" class="datetime">Aug 15, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">Access to Healthcare</span></span> <h3 class="views-field views-field-title"><span class="field-content">Negative impact of the IRA on patient access to innovative treatments</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms. </p></span></div> </a> </li> <li class="each-item"> <a href="/stories/every-number-has-story-my-journey-novartis-refugee"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-08/svitlana-junior-project-manager-giving-volunteering.jpg.webp?itok=OQja6Ya7" alt="Svitlana, Junior Project Manager, Giving & Volunteering" title="Svitlana, Junior Project Manager, Giving & Volunteering" width="2736" height="1824" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-08-13T13:51:55Z" class="datetime">Aug 13, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <h3 class="views-field views-field-title"><span class="field-content">Every number has a story – my journey to Novartis as a Refugee</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>The current refugee crisis is one of the world's greatest humanitarian challenges. Svitlana shares her story of her journey to Novartis and how her work as part of the Giving and Volunteering team is opening the doors to refugees and other marginalized groups and allowing our people to make a difference by helping those who are most vulnerable.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/diversity-equity-and-inclusion-dei-really-important"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-08/nidesh-and-saswati.jpg.webp?itok=9AkSihR0" alt="Nidesh, Head of Finance for Data, Digital & IT. And Saswati, Country HR Business Partner for Data, Digital & IT" title="Nidesh, Head of Finance for Data, Digital & IT. And Saswati, Country HR Business Partner for Data, Digital & IT" width="1920" height="1440" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-08-02T10:55:42Z" class="datetime">Aug 02, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <h3 class="views-field views-field-title"><span class="field-content">Is Diversity, Equity and Inclusion (DEI) really that important?</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p><span>We think so and here are just some of the reasons why: we believe our workplace should reflect today’s emerging workforce; every culture needs diversity to thrive; and it supports fair treatment and opportunities for all our people.</span></p></span></div> </a> </li> <li class="each-item"> <a href="/stories/legacy-blood-cancer-innovation"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-09/scientists-looking-at-a-tablet-in-a-laboratory.jpg.webp?itok=Nf8W0NHJ" alt="Scientists in a laboratory looking at a tablet" title="Scientists in a laboratory looking at a tablet" width="1920" height="620" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-05-31T17:59:16Z" class="datetime">May 31, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">Discovery</span></span> <h3 class="views-field views-field-title"><span class="field-content">A legacy of blood cancer innovation</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>Building on more than two decades of chronic myeloid leukemia research, the R&D teams at Novartis pursued an investigational treatment unlike any other.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/personal-journey-full-circle-from-curiosity-about-life-earth-transformative-therapies-novartis"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-05/michelle-l-krishnan-executive-director-md-phd.png.webp?itok=HVTssUY3" alt="Michelle L Krishnan, Executive Director, MD PhD " title="Michelle L Krishnan, Executive Director, MD PhD " width="1920" height="1077" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-05-27T09:10:31Z" class="datetime">May 27, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <h3 class="views-field views-field-title"><span class="field-content">A personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>From curiosity about life on Earth to transformative therapies at Novartis. Michelle L Krishnan, Executive Director, MD PhD.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/from-black-holes-ai-driven-drug-discovery-collaboration-wins-day"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-04/bulent-kiziltan-portait.jpg.webp?itok=111O4wCu" alt="portrait of Dr Bülent Kızıltan, Global Head of AI & Computational Sciences" title="Dr Bülent Kızıltan, Global Head of AI & Computational Sciences" width="1200" height="800" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-04-29T14:00:00Z" class="datetime">Apr 29, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <h3 class="views-field views-field-title"><span class="field-content">From black holes to AI driven drug discovery – collaboration wins the day</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>Dr Bülent Kızıltan, Global Head of AI & Computational Sciences</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/drug-delivery-service-delivery-and-future-cancer-care"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-04/novartis-indianapolis-rlt-1920x620.jpg.webp?itok=I_qNEZl4" alt="A highly trained Novartis specialist dresses in full personal protective equipment to work on the radioligand therapy production line" title="A highly trained Novartis specialist dresses in full personal protective equipment to work on the radioligand therapy production line" width="3424" height="1105" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-04-08T16:12:21Z" class="datetime">Apr 08, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">From Our Labs</span></span> <h3 class="views-field views-field-title"><span class="field-content">Drug delivery, service delivery, and the future of cancer care</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery.</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/listening-cml-patient-community"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-02/japanese-doctor-patients-discussing-illness.jpg.webp?itok=G4gK3gfD" alt="Japanese doctor and patients discussing illness" title="Japanese doctor and patients discussing illness" width="2000" height="646" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-02-14T06:00:00Z" class="datetime">Feb 14, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">Patient Perspectives</span></span> <h3 class="views-field views-field-title"><span class="field-content">Listening to the CML patient community</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>Improving the patient experience and removing potential barriers to clinical trial participation</p></span></div> </a> </li> <li class="each-item"> <a href="/stories/how-collaboration-can-enhance-your-science-career"> <div class="views-field views-field-field-story-image views-field-field-featured-image-1"><span class="field-content"> <img src="/sites/novartis_com/files/styles/list_view_image_660_370/public/2024-02/portrait-kumar-veerapen-banner.jpg.webp?itok=i7RUCj7y" alt="Kumar Veerapen, Senior Expert Data Science sitting with a dog in front of windows" title="Kumar Veerapen, Senior Expert Data Science sitting with a dog in front of windows" width="1500" height="484" loading="lazy" /></span></div> <span class="views-field views-field-nothing views-field-type"><span class="field-content">Story</span></span> <span class="views-field views-field-field-date views-field-nothing"><span class="field-content"><time datetime="2024-02-08T09:13:49Z" class="datetime">Feb 08, 2024</time> </span></span> <span class="views-field views-field-field-category views-field-nothing"><span class="field-content">People and Culture</span></span> <h3 class="views-field views-field-title"><span class="field-content">How collaboration can enhance your science career</span></h3> <div class="views-field views-field-field-story-intro-text"><span class="field-content"><p>Kumar Veerapen, Senior Expert I Data Science</p></span></div> </a> </li> </ul> </div> </div> </div> </div> </div> </div> <div class='clearfix grid-description block text-formatted field'><p><a class="button_text element_margin link_button button-border" href="/news/news-archive">All news</a></p><hr></div> </div> <div class="field__item"> <div class="enable-zoom paragraph paragraph--type--media-content paragraph--view-mode--default"> <div class="row background_white text_clr_black text-on-left-side"> <div class="col-lg-6 order-lg-2 media_stripe_img"> <div class="image-inner"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cta_image/public/2025-01/novartis-q4-2024-media-content.jpg.webp?itok=UbkxgI8b" alt="Full-year/Q4 2024" title="Full-year/Q4 2024" /> </div> </div> <div class="col-lg-6 order-lg-1 media_stripe_text"> <h2 class="stripe_title " > Novartis 2024 Financial Results </h2> <p class="stripe_subtitle"> <div class="clearfix text-formatted field field--name-field-media-content-description field--type-text-long field--label-hidden field__item"><p>Novartis announced the company’s fourth quarter and 2024 full year financial results.</p></div> </p> <div class="grid_class_cta_wrapper grid_class_button_wrapper "> <div class="field field--name-field-button-text-and-url field--type-entity-reference-revisions field--label-hidden field__item"> <div class="cta-teaser button-teaser mb-3 mt-3"> <a class="link_button button_text" href="/events/novartis-2024-financial-results" target="_self" title="Learn more" >Learn more</a> </div> </div> </div> </div> </div> </div> </div> <div class="field__item"> <div class="paragraph paragraph--type--rich-text-content paragraph--view-mode--default"> <div class="clearfix text-formatted field field--name-field-content field--type-text-with-summary field--label-hidden field__item"><hr><p> </p></div> </div> </div> <div class="field__item"> <div class="enable-zoom paragraph paragraph--type--cards paragraph--view-mode--default"> <div class="container"> <div class="field field--name-field-card-type field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--_-columns-1-2-and-1-2-card paragraph--view-mode--default"> <div class="row common-card-wrapper"> <a href ="/sites/novartis_com/files/novartis-integrated-report-2024.pdf" class="card_wrapper card_base col-md-6 image_yes" target="_blank"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2025-01/portrait-of-kate-kostelyk-and-her-labrador.jpg.webp?itok=DERlFlDN" alt="Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida" title="Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida" width="1551" height="1034" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Novartis in Society Integrated Report 2024 </h3> <p class="basic_paragraph">The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and describes how we create sustainable value for stakeholders and society.</p> </div> </div> </a> <a href ="/sites/novartis_com/files/novartis-annual-report-2024.pdf" class="card_wrapper card_base col-md-6 image_yes" target="_blank"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2025-01/prof-dr-ulf-landmesser-at-charite-hospital-berlin-germany.jpg.webp?itok=Kk1_Hnan" alt="Prof. Dr. Ulf Landmesser (center) at the Charité hospital in Berlin, Germany" title="Prof. Dr. Ulf Landmesser (center) at the Charité hospital in Berlin, Germany" width="2000" height="1334" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Annual Report 2024 </h3> <p class="basic_paragraph">The Annual Report 2024, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices.</p> </div> </div> </a> </div> </div> </div> </div> </div> </div> </div> <div class="field__item"> <div class="paragraph paragraph--type--rich-text-content paragraph--view-mode--default"> <div class="clearfix text-formatted field field--name-field-content field--type-text-with-summary field--label-hidden field__item"><hr></div> </div> </div> <div class="field__item"> <div class="enable-zoom paragraph paragraph--type--cards paragraph--view-mode--default"> <div class="container"> <div class="field field--name-field-card-type field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--_-columns-1-2-and-1-2-card paragraph--view-mode--default"> <div class="row common-card-wrapper"> <a href ="https://www.novartis.com/stories" class="card_wrapper card_base col-md-6 image_yes" target="_self"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2021-08/doctor-baby-rwanda.jpg.webp?itok=PhzeaprQ" alt="Doctor examining baby in Rwanda" title="Doctor examining baby in Rwanda" width="1280" height="485" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Stories </h3> <p class="basic_paragraph">Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.</p> </div> </div> </a> <a href ="https://live.novartis.com" class="card_wrapper card_base col-md-6 image_yes" target="_self"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2021-10/live-maagazine-cover-image.jpg.webp?itok=1fN1Z-Bp" alt="Live Magazine" title="Live Magazine" width="800" height="312" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Live Magazine </h3> <p class="basic_paragraph">Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.</p> </div> </div> </a> </div> </div> </div> </div> </div> </div> </div> <div class="field__item"> <div class="enable-zoom paragraph paragraph--type--cards paragraph--view-mode--default"> <div class="container"> <div class="field field--name-field-card-type field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <div class="paragraph paragraph--type--_-columns-1-2-and-1-2-card paragraph--view-mode--default"> <div class="row common-card-wrapper"> <a href ="/contacts/media-contacts" class="card_wrapper card_base col-md-6 image_yes" target="_self"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2021-10/contacts.jpg.webp?itok=fNz3CMg4" alt="Office Cubicle" title="Office Cubicle" width="400" height="238" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Media contacts </h3> <p class="basic_paragraph">Find contacts at Novartis for media and journalist inquiries from the general and individual contacts.</p> </div> </div> </a> <a href ="https://www.novartis.com/news/media-library" class="card_wrapper card_base col-md-6 image_yes" target="_self"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2021-08/digital-health-providing-opportunity-new.jpg.webp?itok=dYRc4jxi" alt="Narrow photography of a man using a tablet" title="Narrow photography of a man using a tablet" width="1320" height="499" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Media library </h3> <p class="basic_paragraph">Browse and download multimedia resources including images, videos, infographics and more.</p> </div> </div> </a> </div> </div> </div> <div class="field__item"> <div class="paragraph paragraph--type--_-columns-1-2-and-1-2-card paragraph--view-mode--default"> <div class="row common-card-wrapper"> <a href ="/events" class="card_wrapper card_base col-md-6 image_yes" target="_self"> <div class="card_type_full card_image_video"> <div class="card_img"> <div class="video-content"> </div> <div class="img-wrapper"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cards_50_50/public/2024-10/medicine-exhibition-novartis-pavillon.jpg.webp?itok=iCRTSLrr" alt="Medicine Exhibition at Novartis Pavillon" title="Medicine Exhibition at Novartis Pavillon" width="1000" height="386" /> </div> </div> <div class="card_content"> <h3 class="card_title " > Events </h3> <p class="basic_paragraph">Keep informed about the latest Novartis events. From upcoming congresses and conferences to special forums, explore our event calendar for ongoing opportunities to connect and engage.</p> </div> </div> </a> <div class="card_type_feature card_image_video"> <div class="card_img"> <div class="video-content"> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div class="field__item"> <div class="paragraph paragraph--type--slideshow-carousel paragraph--view-mode--default full_width_banners_variant"> <div id="paragraph--32271" class="carousel slide " data-interval="6000" data-bs-ride="carousel" data-pause="true" > <div class="carousel-inner"> <div class="full-width-banner-opt1-orange-graphic polaris-variant large carousel-item active "> <div class="carousel_img_video_image"> <div class="field field--name-field-image field--type-image field--label-hidden field__item"> <picture> <source srcset="/sites/novartis_com/files/styles/banner_image_1920/public/2023-01/desk-newsroon-novartis-news-ig-li.jpg.webp?itok=56r1Aj58 1x" media="(min-width: 1025px)" type="image/webp" width="1920" height="620"/> <source srcset="/sites/novartis_com/files/styles/banner_image_tablet/public/2023-01/desk-newsroon-novartis-news-ig-li.jpg.webp?itok=MctgYwTB 1x" media="(min-width: 768px) and (max-width: 1024px)" type="image/webp" width="1024" height="620"/> <source srcset="/sites/novartis_com/files/styles/banner_image_mobile/public/2023-01/desk-newsroon-novartis-news-ig-li.jpg.webp?itok=hWjdTEvh 1x" media="(min-width: 416px) and (max-width: 767px)" type="image/webp" width="767" height="280"/> <source srcset="/sites/novartis_com/files/styles/banner_image_mobile_portrait/public/2023-01/desk-newsroon-novartis-news-ig-li.jpg.webp?itok=jTrhJM_w 1x" media="(max-width: 415px)" type="image/webp" width="415" height="280"/> <img loading="lazy" src="/sites/novartis_com/files/styles/banner_image_1920/public/2023-01/desk-newsroon-novartis-news-ig-li.jpg.webp?itok=56r1Aj58" width="1920" height="620" alt="View of a desk with a cup, a phone and a monitor on it containing Novartis social media accounts" title="View of a desk with a cup, a phone and a monitor on it containing Novartis social media accounts" typeof="foaf:Image" /> </picture> </div> </div> <div class="carousel_variant"> <div class="carousel-caption d-md-block content_box left "> <div class="container"> <div class="carousel_inner--wrapper "> <h2 class="stripe_title"> <a href="https://twitter.com/NovartisNews" title="#NovartisNews" >#NovartisNews</a> </h2> <p class="carousel_desc">Tweets from the Media Relations team</p> <div class="carousel_link_button"> <a class="button_text element_margin" href="https://twitter.com/NovartisNews" title="Follow @NovartisNews" >Follow @NovartisNews</a> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div class="field__item"> <div class="enable-zoom paragraph paragraph--type--media-content paragraph--view-mode--default"> <div class="row background_white text_clr_black text-on-left-side"> <div class="col-lg-6 order-lg-2 media_stripe_img"> <div class="image-inner"> <img class="img img-fluid" src="/sites/novartis_com/files/styles/cta_image/public/2021-09/lp-newsroom-social-media.jpg.webp?itok=P-ARKD8b" alt="Novartis media relations on LinkedIn" title="Novartis media relations on LinkedIn" /> </div> </div> <div class="col-lg-6 order-lg-1 media_stripe_text"> <h2 class="stripe_title " > Get the latest news and updates from Novartis directly to your inbox. </h2> <p class="stripe_subtitle"> </p> <div class="grid_class_cta_wrapper grid_class_button_wrapper "> <div class="field field--name-field-button-text-and-url field--type-entity-reference-revisions field--label-hidden field__item"> <div class="cta-teaser button-teaser mb-3 mt-3"> <a class="link_button button_text" href="/news/stay-up-to-date" target="_self" title="Subscribe" >Subscribe</a> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div class="content_bottom"> </div> </div> </div> </article> </div> </div> </section> </div> </div> </div> </div> <div class="container clearfix content_bottom"> <div class="clearfix text-formatted field--name-field-disclaimer field--type-text-with-summary"> <script> document.addEventListener('DOMContentLoaded', function() { var link = document.querySelector('a[href="#tab-key-release"]'); if (link) { link.textContent = 'Key Releases'; } var link = document.querySelector('a[href="#tab-statement"]'); if (link) { link.textContent = 'Statements'; } var link = document.querySelector('a[href="#tab-pulse-update"]'); if (link) { link.textContent = 'Pulse Updates'; } }); </script><style> div.content_bottom .field--name-field-disclaimer { border-top: none !important; } </style> </div> </div> </div> <footer > <div class="site-footer"> <div class="container"> <section class="row region region-footer-menu"> <div id="block-polaris-novartisglobal" data-block-plugin-id="block_content:f15c8c31-8ede-4e83-9fdd-344ea44dcd35" class="block-content-text block block-block-content block-block-contentf15c8c31-8ede-4e83-9fdd-344ea44dcd35"> <h2>Novartis</h2> </div> </section> </div>  <div class="footer-widgets">  <div class="container"> <div class="row">  <div class = "col-lg-3"> <section class="row region region-footer-first"> <nav role="navigation" aria-labelledby="block-polaris-navigatetonovartis-menu" id="block-polaris-navigatetonovartis" data-block-plugin-id="system_menu_block:navigate-to-novartis" class="block block-menu navigation menu--navigate-to-novartis"> <div class='accordion_item_wrapper accordion-stripe-close'> <h6 id="block-polaris-navigatetonovartis-menu" >Working together</h6> <button class="footer_accordion accordion-toggle accordion-stripe-title" data-bs-toggle="collapse">Working together</button> <div class='accordion-stripe-body'> <div class="footer-nav-links"> <ul class="clearfix nav"> <li class="nav-item"> <a href="/patients-and-caregivers" class="nav-link nav-link--patients-and-caregivers" data-drupal-link-system-path="node/24106">Patients and caregivers</a> </li> <li class="nav-item"> <a href="/healthcare-professionals" class="nav-link nav-link--healthcare-professionals" data-drupal-link-system-path="node/24166">Healthcare professionals</a> </li> <li class="nav-item"> <a href="/research-and-development" class="nav-link nav-link--research-and-development" data-drupal-link-system-path="node/24201">Researchers</a> </li> <li class="nav-item"> <a href="/careers" class="nav-link nav-link--careers" data-drupal-link-system-path="node/1101">Job seekers</a> </li> <li class="nav-item menu-item--active-trail"> <a href="/news" class="nav-link active nav-link--news is-active" data-drupal-link-system-path="node/24551" aria-current="page">Journalists</a> </li> <li class="nav-item"> <a href="/investors" class="nav-link nav-link--investors" data-drupal-link-system-path="node/11976">Investors</a> </li> </ul> </div> </div> </div> </nav> </section> </div>   <div class = "col-lg-3"> <section class="row region region-footer-second"> <nav role="navigation" aria-labelledby="block-polaris-aboutnovartis-menu" id="block-polaris-aboutnovartis" data-block-plugin-id="system_menu_block:about-novartis" class="block block-menu navigation menu--about-novartis"> <div class='accordion_item_wrapper accordion-stripe-close'> <h6 id="block-polaris-aboutnovartis-menu" >Topics</h6> <button class="footer_accordion accordion-toggle accordion-stripe-title" data-bs-toggle="collapse">Topics</button> <div class='accordion-stripe-body'> <div class="footer-nav-links"> <ul class="clearfix nav"> <li class="nav-item"> <a href="/events/novartis-2024-financial-results" target="_self" class="nav-link nav-link--events-novartis-2024-financial-results" data-drupal-link-system-path="node/663221">Q4 2024</a> </li> <li class="nav-item"> <a href="/eurovision" target="_self" class="nav-link nav-link--eurovision" data-drupal-link-system-path="node/665846">Eurovision</a> </li> <li class="nav-item"> <a href="/esg/access" class="nav-link nav-link--esg-access" data-drupal-link-system-path="node/34011">Access</a> </li> <li class="nav-item"> <a href="/esg" class="nav-link nav-link--esg" data-drupal-link-system-path="node/24276">ESG</a> </li> <li class="nav-item"> <a href="/esg/ethics-risk-and-compliance/ethical-behavior/speakup" class="nav-link nav-link--esg-ethics-risk-and-compliance-ethical-behavior-speakup" data-drupal-link-system-path="node/45196">SpeakUp</a> </li> </ul> </div> </div> </div> </nav> </section> </div>   <div class = "col-lg-3"> <section class="row region region-footer-third"> <nav role="navigation" aria-labelledby="block-polaris-contactus-menu" id="block-polaris-contactus" data-block-plugin-id="system_menu_block:contact-us" class="block block-menu navigation menu--contact-us"> <div class='accordion_item_wrapper accordion-stripe-close'> <h6 id="block-polaris-contactus-menu" >Explore</h6> <button class="footer_accordion accordion-toggle accordion-stripe-title" data-bs-toggle="collapse">Explore</button> <div class='accordion-stripe-body'> <div class="footer-nav-links"> <ul class="clearfix nav"> <li class="nav-item"> <a href="/research-development/novartis-pipeline" class="nav-link nav-link--research-development-novartis-pipeline" data-drupal-link-system-path="global-pipeline">Pipeline</a> </li> <li class="nav-item"> <a href="/about/products" class="nav-link nav-link--about-products" data-drupal-link-system-path="products">Products</a> </li> <li class="nav-item"> <a href="/clinicaltrials" class="nav-link nav-link--clinicaltrials" data-drupal-link-system-path="node/24141">Clinical trials</a> </li> <li class="nav-item"> <a href="/partnering" class="nav-link nav-link--partnering" data-drupal-link-system-path="node/34001">Partnering</a> </li> <li class="nav-item"> <a href="/events" class="nav-link nav-link--events" data-drupal-link-system-path="node/662076">Events</a> </li> </ul> </div> </div> </div> </nav> </section> </div>   <div class = "col-lg-3"> <section class="row region region-footer-fourth"> <nav role="navigation" aria-labelledby="block-polaris-ourportfolio-menu" id="block-polaris-ourportfolio" data-block-plugin-id="system_menu_block:our-portfolio" class="block block-menu navigation menu--our-portfolio"> <div class='accordion_item_wrapper accordion-stripe-close'> <h6 id="block-polaris-ourportfolio-menu" >Therapeutic areas</h6> <button class="footer_accordion accordion-toggle accordion-stripe-title" data-bs-toggle="collapse">Therapeutic areas</button> <div class='accordion-stripe-body'> <div class="footer-nav-links"> <ul class="clearfix nav"> <li class="nav-item"> <a href="/about/therapeutic-areas/cardiovascular-renal-and-metabolic" class="nav-link nav-link--about-therapeutic-areas-cardiovascular-renal-and-metabolic" data-drupal-link-system-path="node/621016">Cardiovascular, renal and metabolic</a> </li> <li class="nav-item"> <a href="/about/therapeutic-areas/immunology" class="nav-link nav-link--about-therapeutic-areas-immunology" data-drupal-link-system-path="node/575131">Immunology</a> </li> <li class="nav-item"> <a href="/about/therapeutic-areas/neuroscience" class="nav-link nav-link--about-therapeutic-areas-neuroscience" data-drupal-link-system-path="node/574976">Neuroscience</a> </li> <li class="nav-item"> <a href="/about/therapeutic-areas/oncology" class="nav-link nav-link--about-therapeutic-areas-oncology" data-drupal-link-system-path="node/621176">Oncology</a> </li> </ul> </div> </div> </div> </nav> </section> </div> </div> </div> </div> <div class="footer-widgets middle-footer-section">  <div class="container"> <div class="row">   <div class = "col-lg-5 middle_footer_left"> <section class="row region region-footer-middle-first"> <div id="block-polaris-socialmedialinks" data-block-plugin-id="social_media_links_block" class="block-social-media-links block block-social-media-links-block"> <div class="content"> <ul class="social-media-links--platforms platforms inline horizontal"> <li> <a class="social-media-link-icon--linkedin" href="https://www.linkedin.com/company/novartis" rel="noopener noreferrer" target="_blank" aria-label="LinkedIn" title="LinkedIn" > <span class='fab fa-linkedin fa-2x'></span> </a> </li> <li> <a class="social-media-link-icon--facebook" href="https://www.facebook.com/novartis" rel="noopener noreferrer" target="_blank" aria-label="Facebook" title="Facebook" > <span class='fab fa-facebook fa-2x'></span> </a> </li> <li> <a class="social-media-link-icon--twitter" href="https://x.com/novartis" rel="noopener noreferrer" target="_blank" aria-label="X formerly known as Twitter" title="X formerly known as Twitter" > <span class='fab fa-x-twitter fa-2x'></span> </a> </li> <li> <a class="social-media-link-icon--instagram" href="https://www.instagram.com/novartis" rel="noopener noreferrer" target="_blank" aria-label="Instagram" title="Instagram" > <span class='fab fa-instagram fa-2x'></span> </a> </li> <li> <a class="social-media-link-icon--youtube" href="https://www.youtube.com/user/novartis" rel="noopener noreferrer" target="_blank" aria-label="Youtube" title="Youtube" > <span class='fab fa-youtube fa-2x'></span> </a> </li> </ul> </div> </div> </section> </div>  <div class = "col-lg-6 offset-lg-1 middle_footer_right"> <section class="row region region-footer-middle-second"> <div class="search-block-form block block-arctic-search block-search-form-block" data-drupal-selector="search-block-form" id="block-polaris-searchform" data-block-plugin-id="search_form_block"> <div> <div class="content"> <form action="/search" method="get" id="search-block-form" accept-charset="UTF-8" class="search-form search-block-form form-row"> <div class="js-form-item js-form-type-textfield form-type-textfield js-form-item-keyword form-item-keyword form-no-label mb-3"> <label class="searchForm visually-hidden" for="edit-keys">Footer Site Search</label> <div> <input placeholder="Search" id="edit-keys" data-drupal-selector="edit-keyword" type="text" name="keyword" value="" size="60" maxlength="128" class="form-text form-control arc-input"/> </div> </div> <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper mb-3" id="edit-actions--3"><div> <input data-drupal-selector="edit-submit" type="submit" id="edit-submit--2" value="Footer Search" class="button js-form-submit form-submit btn btn-primary form-control arc-input"/> </div> </div> </form> </div> </div> </div> </section> </div>  </div> </div> </div> <div class="footer_bottom"> <div class="container"> <section class="row region region-footer-bottom"> <nav role="navigation" aria-labelledby="block-polaris-footerbottom-menu" id="block-polaris-footerbottom" data-block-plugin-id="system_menu_block:footer-bottom" class="block block-menu navigation menu--footer-bottom"> <div class='accordion_item_wrapper accordion-stripe-close'> <h6 class="sr-only" id="block-polaris-footerbottom-menu" >Footer Bottom</h6> <button class="footer_accordion accordion-toggle accordion-stripe-title" data-bs-toggle="collapse">Footer Bottom</button> <div class='accordion-stripe-body'> <div class="row footer-bottom-section" > <div class="col-lg-8"> <span class="novartis-text"> © 2025 Novartis AG</span> <div class="bottom-organsim"> <ul class="clearfix nav navbar-nav"> <li class="nav-item"> <a href="/terms-use" class="nav-link nav-link--terms-use" data-drupal-link-system-path="node/36">Terms of use</a> </li> <li class="nav-item"> <a href="/privacy" class="nav-link nav-link--privacy" data-drupal-link-system-path="node/41">Privacy</a> </li> <li class="nav-item"> <a href="#cookie-settings-button" class="ot-sdk-show-settings nav-link nav-link-cookie-settings-button">Cookie settings</a> </li> <li class="nav-item"> <a href="/contacts" class="nav-link nav-link--contacts" data-drupal-link-system-path="node/24146">Contacts</a> </li> <li class="nav-item"> <a href="/about/locations" class="nav-link nav-link--about-locations" data-drupal-link-system-path="our-company/contact-us/office-locations">Locations</a> </li> <li class="nav-item"> <a href="/sitemap.xml" class="nav-link nav-link--sitemapxml" data-drupal-link-system-path="sitemap.xml">Site map</a> </li> <li class="nav-item"> <a href="/open-source" class="nav-link nav-link--open-source" data-drupal-link-system-path="node/73846">Open source</a> </li> <li class="nav-item"> <a href="/accessibility" class="nav-link nav-link--accessibility" data-drupal-link-system-path="node/86496">Web accessibility</a> </li> </ul> </div> </div> <div class="col-lg-4"> <div class="site_directory"> <a class="globe-icon" href="/novartis-directory" aria-label="Novartis Site Directory" title="Novartis Site Directory"> <span class="dir-text">Novartis Site Directory</span> </a> </div> <div class="novartis-text-global">This site is intended for a global audience</div> </div> </div> </div> </div> </nav> </section> </div> </div> </div> </footer> </div> <script>window.dataLayer = window.dataLayer || []; window.dataLayer.push({"drupalLanguage":"en","drupalCountry":"CH","siteName":"Novartis","entityCreated":"1629988998","entityLangcode":"en","entityStatus":"1","entityUid":"701","entityUuid":"04cf3449-bc1c-4c8f-82f4-042ae63120be","entityVid":"10994056","entityName":"kabagke1","entityType":"node","entityBundle":"landing_page","entityId":"24551","entityTitle":"News","primaryCategory":"news","entityTaxonomy":{"sections":{"6":"Global"}},"userUid":0});</script> <script src="/sites/novartis_com/files/js/js_26aBeVx9C4WI5YDAP9NsVwFbvGbJ8pWBR4KYM0JkX9s.js?scope=footer&delta=0&language=en&theme=polaris&include=eJx1kuuO3CAMhV-IBGlVterTWA7xECaAkXGyk7ev57LRdqX5hc9nrGOMcZ6VsR4eX8F4Ea7qUIKmAF05rGDRSuK_C4e9k0KqVwrK4q99tBL49fHn91_oC4uCkhSgumANVKgq8AV0IVhIGHaUhMZS7xsBVyjsZlTMeJjTRAvuiaU7umlOdfWzbA3z-JJuYtaugg0mFEnsY-YJ89D1sHx0jbMZ9Hf4LD_JnmbioZn9kFPXk9e9D6lgpCFiziSHe9wEKhPNsGLWTdC_zid1kTlmAsXoo5b_JcafesQr3lxgXhM1YX9GZw82FxKskdpz9J8EhSLaTDd_YSnjJw13MNzJ8Pg_qrOrAbJVbdY8dMrPfzpJ4K2qHGfGTaRmA3Rr3O1pl5RN2gSpmnl-l8ZNGfo2laSuk63AAtgS3HHg0jIp-Tf8a8cCC_lv8ViwWocPD4KtZcYZvoqA9vsqmbRb8z8xhhVI&0=srtw6f" data-ot-ignore></script> <script src="https://static.addtoany.com/menu/page.js" defer integrity="sha256-JHH0IyzMqEWp2osQ5b6B5zI/qliRuXFfQlZhUF8YNDQ=" crossorigin="anonymous"></script> <script src="/sites/novartis_com/files/js/js_rrOCHT7yYO95GpzGdNYLgBXyJiWJCWt09J5C5fK0_SQ.js?scope=footer&delta=2&language=en&theme=polaris&include=eJx1kuuO3CAMhV-IBGlVterTWA7xECaAkXGyk7ev57LRdqX5hc9nrGOMcZ6VsR4eX8F4Ea7qUIKmAF05rGDRSuK_C4e9k0KqVwrK4q99tBL49fHn91_oC4uCkhSgumANVKgq8AV0IVhIGHaUhMZS7xsBVyjsZlTMeJjTRAvuiaU7umlOdfWzbA3z-JJuYtaugg0mFEnsY-YJ89D1sHx0jbMZ9Hf4LD_JnmbioZn9kFPXk9e9D6lgpCFiziSHe9wEKhPNsGLWTdC_zid1kTlmAsXoo5b_JcafesQr3lxgXhM1YX9GZw82FxKskdpz9J8EhSLaTDd_YSnjJw13MNzJ8Pg_qrOrAbJVbdY8dMrPfzpJ4K2qHGfGTaRmA3Rr3O1pl5RN2gSpmnl-l8ZNGfo2laSuk63AAtgS3HHg0jIp-Tf8a8cCC_lv8ViwWocPD4KtZcYZvoqA9vsqmbRb8z8xhhVI&0=srtw6f" data-ot-ignore></script> </body> </html>

CINXE.COM

News | Novartis